WO1995033504A1 - Ic-processed microneedles - Google Patents

Ic-processed microneedles Download PDF

Info

Publication number
WO1995033504A1
WO1995033504A1 PCT/US1995/007916 US9507916W WO9533504A1 WO 1995033504 A1 WO1995033504 A1 WO 1995033504A1 US 9507916 W US9507916 W US 9507916W WO 9533504 A1 WO9533504 A1 WO 9533504A1
Authority
WO
WIPO (PCT)
Prior art keywords
shaft
substrate
microstructure
interface region
microneedle
Prior art date
Application number
PCT/US1995/007916
Other languages
French (fr)
Inventor
Liwei Lin
Albert Pisano
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Priority to AU29072/95A priority Critical patent/AU2907295A/en
Publication of WO1995033504A1 publication Critical patent/WO1995033504A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/20Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
    • A61B17/205Vaccinating by means of needles or other puncturing devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00178Special arrangements of analysers
    • G01N2035/00237Handling microquantities of analyte, e.g. microvalves, capillary networks
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/4833Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures

Definitions

  • the present invention relates generally to microneedles, and more particularly to microneedles fabricated by micromachining techniques.
  • needles are used to extract samples of substances from living tissue in order to analyze the substances for diagnostic purposes, or to deliver a drug or a medicine.
  • the majority of needles in use today are macroneedles, which have a relatively large diameter as compared to a blood cell and are on the order of millimeters (mm) .
  • the large diameter of the macroneedle shaft has the disadvantage of possibly damaging biological tissue during penetration. Additionally, tissue penetration by the needle is often painful to the patient because of the relatively large needle diameter.
  • microneedles having a diameter on the order of micrometers have many applications. For instance, they may be used as precise injection/extraction needles in cell biology, as injection/extraction heads in a drug delivery system or microchemical factory, and as injection/extraction heads in microsurgery. It is also advantageous to have a smaller size needle because the reduced size decreases discomfort and pain to the patient.
  • Still another object of the present invention is to provide a microneedle which may be mass produced.
  • Yet still another object of the present invention is to provide a microneedle which is strong enough to reliably penetrate biological tissue.
  • a further object of the present invention is to provide a microneedle which may incorporate micropumps, microvalves and microdetectors.
  • the present invention is directed to an IC- processed microneedle formed from a substrate which defines an interface region and an elongated portion extending away from the interface region.
  • a shaft is formed from the elongated region by a shell, which defines an enclosed channel within the shaft. One end of the shaft is attached to the interface region.
  • the shaft includes ports which permit fluid to flow through the microneedle.
  • the method of the present invention includes a sequence of steps for forming an IC-processed microneedle. First, a substrate is provided for forming an interface region and an elongated portion extending away from the interface region. A patterned non-planar etchable structure is then formed on the frontside of the elongated portion of the substrate.
  • An unetchable membrane layer is deposited atop the etchable structure, and etching holes are opened in the membrane layer.
  • One of the etching holes is at an end of the membrane layer and a second etching hole is positioned at a second end of the membrane layer.
  • the etchable structure is etched to a predetermined extent to form a cavity underneath the membrane layer, thereby producing a shaft formed from the membrane layer and the elongated portion of said substrate.
  • Figure 1A is a perspective view of an embodiment of a silicon processed microneedle.
  • Figure IB is a cross-sectional view of the microneedle as taken along line IB-IB of Figure 1A.
  • Figure IC is a cross-sectional view of the microneedle as taken along line 1C-1C of Figure 1A.
  • Figure 2A is a plan view of the microneedle prior to detachment from the substrate.
  • Figure 2B is a cross-sectional view of the microneedle as taken along line 2B-2B of Figure 2A.
  • FIGS 3A-1 to 3N-2 schematically illustrate a microneedle fabrication process according to the present invention.
  • the left-hand figures are taken along line 3L-3L of Figure 1A, and the right-hand figures are taken along line 3R-3R.
  • Figures 4A and 4B are views illustrating a icroheater and its positioning relative to the microchannel, respectively.
  • Figures 5A-5E show the sequence of steps in fabricating the microneedle with on-chip CMOS (complementary metal-oxide semiconductor) as taken along line 5-5 of Figure lA.
  • Figure 6 is a schematic diagram showing the microneedle penetrating tissue in a first application of the present invention.
  • Figure 7 is a schematic diagram including a detailed portion showing the microneedle penetrating tissue in another application of microneedle use.
  • FIGS 8A and 8B show alternative embodiments of the microneedle.
  • the present invention will be described in terms of the preferred embodiment.
  • the preferred embodiment is an apparatus and method for fabricating IC-processed microneedles. Referring in detail to th- drawings, wherein like reference numerals designate like parts in several figures, and initially to FIG. 1A, a microneedle 10 in accordance with the present invention is illustrated.
  • Microneedle 10 includes an interface region 11 and a shaft 14 having a icroflow channel 78 therein along its length.
  • a distal end 20 of shaft 14 can be inserted into tissue (not shown) so that liquids
  • a shank fluid port 22 is located on shank or proximal end 12 of shaft 14 to deliver or receive fluids.
  • the microneedle may include more than two ports, as desired.
  • Microflow channel 78 runs along the length of fully- enclosed microneedle shaft 14.
  • a series of thin polysilicon heating resistors 60 are located on interface region 11 along the floor of microflow channel 78. Interface region 11 is sufficiently thick to permit incorporation of on-chip electronics 24 for real-time fluid analysis. Heating resistors 60 may be used to form a thermally-driven, cascaded-bubble icropump or simple heater.
  • the microneedle may also include detector resistors 62 which extend along the bottom of the icrochannel (see FIG. IB) and are coupled to electrodes 84 (FIG. 3L-2) on the tip 86 of the needle.
  • Microflow channel 78 is formed by removing sacrificial layers from underneath a shell 26 during processing. In order to access the sacrificial layer, etch access holes 74 are opened and then filled after etching. The fabrication procedures will be discussed below in . relation to FIGS. 3A-1 through 3N-2.
  • FIG. IB shows a cross-section of fully-enclosed microflow channel 78.
  • the channel height is approximately 9 ⁇ m, and is indicated by dimension "G” , and the channel width "H” may be between 30 ⁇ m to 60 ⁇ m.
  • the needle height "I” is about 70 ⁇ m, and the needle width "J” is approximately 80 ⁇ m at the tip region.
  • FIG. IC illustrates the positioning of a polysilicon resistor 60 on interface region 11.
  • Contact pads 36 are situated on both sides of the microflow channel 78 at shank end 12 and provide an outside connection to resistors 60, which function as microheaters.
  • detector resistors 62 cannot be seen in FIG. IC because this cross-section is taken along line 1C-1C on the interface region.
  • the detector resistors extend along the length of the channel but do not extend into the interface region any further than is necessary to couple them to electronics 24. The location of both resistors can be best seen in FIG. 3N- 2.
  • FIG. 2A is a plan view of a microneedle 10 before it is separated from wafer or substrate 46 by breaking beams 44.
  • Support beams 44 connect microneedle 10 to substrate 46 and facilitate testing and manipulation of the microneedle prior to its final use.
  • Area 40 marks the area where microneedle 10 will be separated from substrate or thin-film 46.
  • Interface region 11 may be used as an integrated-circuit (IC) interface region of approximately 2 to 3 millimeters (mm) 2 .
  • the tip region 86 is formed at an angle ⁇ of approximately 45° to the plane of the needle shaft 14, to form a sharp triangular tip 87.
  • the width of the interface region, indicated by dimension "X”, is approximately 1.5 mm, and the length of the shaft, indicated by dimension “Y”, is between 1 and 6 mm.
  • interface region 11 widens out to a large surface area, suitable for incorporation of additional integrated electronic and/or fluidic devices.
  • Cross-sectional dimensions of a completed microneedle 10 are shown in FIG. 2B after if has been detached from wafer 46.
  • Wafer 46 has an initial thickness of between 500 and 550 ⁇ m, as indicated by "Z”.
  • the wafer thickness of the microneedle is reduced during fabrication.
  • Shaft 14 has a thickness of approximately 50 ⁇ m indicated by dimension "I”.
  • microneedle 10 tapers from the tip end 86, where it is approximately 80 ⁇ m wide, to 140 ⁇ m, where it joins the shank in order to increase strength.
  • the retained single-crystal silicon layer 46 provides a rigid spine which adds strength to the needle. Note that there is no single- crystal silicon at the tip region 86, so that the tip is sharper and smaller than the portion of the shaft including single-crystal silicon.
  • microneedle The fabrication sequence for formation of a microneedle is shown in FIGS. 3A-1 to 3N-2. Seven masks may be used.
  • the drawings are not to scale, and dimensions should be taken from the text; the drawings are to illustrate the process, and not necessarily the preferred dimensions of the microneedle.
  • the microneedle is formed using IC (integrated circuit) processing methods, e.g. oxidation, lithography, chemical vapor deposition, doping, and etching.
  • IC integrated circuit
  • microchannel 78 is surface-micro achined onto a single-crystal silicon substrate or thin-film 46 that is mostly etched from the wafer backside along shaft 14 in the final fabrication step.
  • FIGS. 3A-1 AND 3A-2 show a ⁇ 100>-oriented lightly doped n-type silicon wafer 46 which is 500-550 ⁇ m thick.
  • a thick masking layer 47 of silicon dioxide (Si0 2 ) 1.2 ⁇ m thick is thermally grown on wafer frontside 48 and backside 50.
  • Masking layer 47 is patterned as shown, and boron is diffused at approximately 1125 °C for fifteen hours to form a 12 ⁇ m-deep heavily doped p-type region 52. Both the future interface region 11 and shaft 14 are indicated generally in these figures.
  • Boron-doped region 52 defines tip region 84 (FIG. 2A) , extends along the needle shaft and defines the perimeter of interface region 11, as best shown in FIG. 2A. Boron-doped region 52 acts as an etchant stop since EDP (ethyleneidamine pyrocatacol and water) , used during fabrication, does not etch boron-doped silicon. Note that the boron-doped region is omitted from the center of IC interface region 11 because, as well known, any electronic components incorporated into the microneedle must be atop undoped silicon.
  • EDP ethyleneidamine pyrocatacol and water
  • Masking layer 47 is then removed, and a 400 nanometer (nm) thick layer 54 of Si0 2 is thermally grown on the wafer.
  • a 600 nm low-stress nitride layer 56 is then deposited by low pressure chemical vapor deposition (LPCVD) for passivation. As well known, CVD will deposit on all exposed surfaces of the wafer. Silicon dioxide layer 54 will serve as a thermal barrier underneath the microheater as well as an electronic insulation layer. Silicon nitride layer 56 serves as the bottom layer of the microchannel.
  • a 600 nm- thick LPCVD phosphorus-doped polycrystalline silicon layer 58 is then deposited, and the resulting structure is as shown in FIGS. 3B-1 and 3B-2.
  • Polysilicon layer 58 is patterned and etched to define polysilicon heating resistors 60 on interface region 11 (FIG. 3C-1) and, if desired, polysilicon detector resistors 62 (FIG. 3C-2) . Note that phosphorus-doped polycrystalline silicon layer 58 is also etched away on backside 50. Resistors 60 are shown perpendicular to the length of channel 78; however, they may also be fabricated such that they extend lengthwise parallel to channel 78 or in any other orientation under the area of fluid flow. Resistors 60 are approximately 50 ⁇ m long. Detector resistors 62 extend lengthwise along shaft 14 and function as wires to relay a signal from electrodes or recording sites 84 (FIG.
  • heating resistors 60 and detector resistors 62 are approximately .5 ⁇ m high, and 2 ⁇ m wide. Heating resistors 60 are approximately 50 ⁇ m long. The length of detector resistors 62 depends upon the eventual length of shaft 14. However, resistors 62 should reach the tip of the needle so that electrodes or recording sites may also be at the needle tip 86.
  • a thin layer 64 of approximately 150 nm of LPCVD low-stress nitride is deposited to cover and protect polysilicon resistors 60 and 62 during subsequent EDP
  • LTO low-temperature oxide
  • the LTO layer on top of the PSG gives better adhesion to photoresist.
  • the LTO layer also desirably minimizes hydrofluoric acid
  • the microflow channel is then patterned and wet- etched in a 5:1 solution of buffered HF, as shown in FIGS. 3E-1 AND 3E-2.
  • the buffered HF etches both PSG 66 and LTO 68 layers as shown.
  • the primary configuration of the channel is formed by this etch.
  • a .5 ⁇ m LTO layer 71 (FIGS. 3F-1 and 3F-2) is then deposited by
  • LTO layer 71 is then patterned and wet-etched in 5:1 BHF (buffered hydrofluoric acid) to provide an etch channels area 70 as shown in FIG. 3F- 1. Dry-etching is also possible for this step.
  • LTO layer 71 is also deposited on backside 50, but is not shown because they it is removed after the BHF wet-etch.
  • the etch channels area 70 is advantageously only about .5 ⁇ m thick because it will be relatively easy to fill etch holes later in the fabrication process, as will become apparent below.
  • Etch access holes 74 and distal 18 and shank 22 fluid ports are defined and etched in a plasma etcher through silicon nitride layer 72.
  • the etch access holes lead to the sacrificial PSG and LTO layers which will be etched.
  • the cross-section appears as in FIG. 3G-1; the etch access holes are not visible in FIG. 3G-2.
  • Etch access holes are formed along the length of the shaft 14 in etch channel area 70, and are located every 25 ⁇ m.
  • the duration of the sacrificial-layer etching step is thus independent of channel length.
  • the etch access holes are approximately 5 ⁇ m x 5 ⁇ m.
  • Fluid ports 18 and 22 will permit flow of a liquid through the microchannel 78 when the needle is fully operational.
  • the fluid ports are approximately 20 ⁇ m x 20 ⁇ m.
  • distal fluid port 18 is positioned 150 ⁇ m up the microneedle from the tip 86. Since the PSG and LTO layers are underneath nitride layer 72,. resistors 60 and 62 will not be affected by this etch.
  • the fluid ports are relatively large as compared to the etch access holes, the fluid ports will not be completely filled during deposition of silicon nitride sealing layer 76, in which etch access holes are sealed (described below) .
  • the fluid ports may be etched after the sacrificial PSG and LTO layers are removed from within the microchannel if good process control is employed.
  • this method has the possible drawback of affecting silicon nitride 64, which protects resistors 60 and 62. Since layer 64 is approximately 150 nm, the resistors will not be affected because the etch will remove about 50 nm of layer 64.
  • resistors 60 and 62 may be located so that they will not be underneath the fluid ports.
  • the wafer is immersed in concentrated hydrofluoric acid (48% HF) for approximately 2.5 minutes to remove PSG layer 66, and LTO layers 68 and 71 underneath nitride shell 72. Wafer 46 is then rinsed in de-ionized water, snd any residual oxide is removed from the silicon nitride 72 using HF. The resulting microneedle is then as shown in FIGS. 3H-1 and 3H-2.
  • concentrated hydrofluoric acid (48% HF) for approximately 2.5 minutes to remove PSG layer 66, and LTO layers 68 and 71 underneath nitride shell 72.
  • Wafer 46 is then rinsed in de-ionized water, snd any residual oxide is removed from the silicon nitride 72 using HF.
  • the resulting microneedle is then as shown in FIGS. 3H-1 and 3H-2.
  • All etch access holes 74 are sealed by deposition of an additional 1.5 ⁇ m thick layer 76 of LPCVD low- stress nitride to form a shell 26, as shown in FIGS. 31- 1 and 31-2. Since the thickness of the PSG before etching was only about .5 ⁇ m underneath the etch access holes 74, a 1.5 ⁇ m deposition of silicon nitride insures that the hole will be completely filled. Microchannel 78 is thus completely sealed, except for the fluid ports. Fluid ports 18 and 22 are sufficiently wide that they will not be sealed by deposition of the 1.5 ⁇ m silicon nitride sealing layer. The size of the fluid ports is somewhat reduced during this step, but they remain sufficiently large enough to permit adequate fluid flow. A thin layer 76 of silicon nitride is also deposited in channel 78, as shown.
  • channel 78 without including etch access holes 74 by using the fluid ports to remove the sacrificial PSG and LTO layers.
  • this approach would require more time to fully evacuate the channel.
  • a clear advantage would be that the previous sealing step could be omitted.
  • EDP etch pre-openings or windows 80 are patterned by a mask and plasma etched in order to facilitate final separation of microneedle 10 from the rest of the wafer, as shown in FIGS. 3J-1 and 3J-2.
  • Etch windows 80 are stopped at the 400 nm-thick Si0 2 layer 54. The etch windows will facilitate removal of the microneedle from the wafer during subsequent backside etch.
  • an electrode hole 82 is formed by patterning and plasma-etching down to the 600 nm-thick phosphorus-doped polycrystalline silicon layer 58 to permit electrical contact with resistors 62. Only a single electrode hole 82 is shown in FIG. 3K-2 (the electrode is not visible in FIG. 3K-1) , but the process for fabricating contact pads 36 (see FIG. IC) is identical and is performed at the same time as electrode fabrication.
  • the electrodes function as recording sites at distal end 20 and permit monitoring of biological electrical activity, as will be discussed below.
  • the contact pads permit coupling of electronics with heating resistors 62.
  • electrode hole 82 After electrode hole 82 is formed, a thin layer of titanium is deposited, followed by a thicker layer of platinum which completely fills the hole, forming a complete electrode 84 as shown in FIG. 3L-1. Again, the electrode is not visible in FIG. 3L-2.
  • microneedle 10 is essentially complete and must now be partially separated from wafer 46.
  • the backside of the wafer is patterned with a blank mask and without alignment to open the etching areas of individual die to free the microneedles from the wafer backside.
  • the mask is positioned so that the microneedle tip extends to the blank center of the mask.
  • Shank end 12 is covered by the mask and is not etched, but distal end 18 is not covered by the mask and so end 18 is completely etched.
  • a timed EDP etch reduces the silicon wafer thickness to 120 ⁇ m, as shown in FIGS. 3M-1 and 3M-2.
  • Pre-EDP etch window 80 is thus deepened so that it extends to undoped silicon layer 46.
  • the microneedle is then partially separated from the wafer, and remains attached through support beams 44, best shown in FIG. 2A. Since the many microneedles fabricated on wafer remain attached to the wafer, it is easier to package, transport, and handle the needles than if they were fully freed by the anisotropic etch. When a free-standing microneedle is desired, the microneedle is simply detached from the rest of the wafer by using, for example, tweezers or some other similar implement to apply pressure to beams 44. When the beams are broken, the microneedle is freed from the wafer.
  • FIG. 4A shows a simplified view of resistor 60 and contact pads 36 (also FIG. IC) of microneedle 10 (not shown) .
  • the contact pads and resistor are defined on a single-doped polysilicon layer.
  • a silicon dioxide layer 54 separates silicon substrate 46 and the contact pads and resistor.
  • Resistor 60 functions as a microheater when a voltage source 30 supplies current to contact pads 36.
  • the resistors propel a liquid to distal fluid port 18, as explained below.
  • FIG. 4B illustrates the positioning of microneedle shell 26 above resistors 60.
  • Si0 2 layer 54 acts as an insulator.
  • the temperature of undoped silicon substrate 46 remains at the ambient temperature.
  • the heaters are especially advantageous if a chemical reaction occurs quickly in response to heat. The reaction may occur in the microneedle and then may be quickly delivered to the appropriate tissue.
  • a single resistor is shown in FIGS. 4A and 4B to illustrate its positioning.
  • five resistors 60 form a thermally-driven cascaded bubble pump (FIG. 2A) .
  • the resistor furthest from the needle tip is heated and produces a single vapor bubble.
  • the adjacent resistor is heated and the bubble is moved sequentially down the line of resistors toward the distal end of the needle shaft.
  • the resistors are heated quickly and sequentially, so that precise fluid control is possible. If a cascaded bubble pump is not employed, a fluid may move down the needle shaft simply by means of gravity.
  • micropumps and microvalves may be incorporated onto the microneedle.
  • the resistors may also be part of a bubble-powered micropump coupled to an actuator.
  • the bubble generation system creates individual, spherical vapor bubbles from 2 to 500 ⁇ m in diameter by locally heating a fluid with a thin film resistor.
  • Prior research has shown that microbubbles are capable of actuating a polycrystalline silicon cantilever (See L. Lin and A.P. Pisano, "Bubble Forming on a Micro Line Heater", Proceedings of ASME Winter Annual Meeting. Micromechanical Sensors. Actuators and Systems. DSC-Vol. 32, pp. 147-163, 1991).
  • micropumps can also be employed with these microneedles, such as those actuated by ultrasonic Lamb waves (See R.M. Moroney, R.M. White and R.T. Howe, "Microtransport Induced by Ultrasonic Lamb Waves,” Applied Physics letters, pp. 774-776, V59, August, 1991); piezoelectrics (See H.T.G. Van Lintel, F.C.M. Van Deol and S. Bouwstra, "A Piezoelectric Micropump Based on Micromachining of Silicon,” Sensors and Actuators. Vol. 15, pp. 153-157, 1988, and M. Esashi, S. Shoji and A.
  • FIGS. 5A-5E briefly illustrate a process for fabricating a microneedle with on-chip CMOS
  • CMOS and BiCMOS complementary metal-oxide semiconductor devices. Both CMOS and BiCMOS are compatible with the microneedle fabrication process. The anufacturability of an on-chip electronic interface with the microneedle is essential for a broad range of applications. The manufacturabilities of the on-chip CMOS and bipolar CMOS devices with the IC-processed microneedle increase the signal conditioning ability, which is not a possible feature in needles fabricated by other means. Formation of the microneedle itself is via the same steps illustrated in FIGS. 3A-1 to 3N-2, and the CMOS devices are fabricated using standard processes. FIGS. 5A-5E, illustrate the best mode sequence for integrating fabrication of both the microneedle and CMOS devices. FIGS.
  • FIG. 5A-5E are taken along line 5-5 of FIG. 1A, although no CMOS devices are shown in FIG. 1A.
  • FIG. 5A is a cross-sectional view of the partially constructed needle shaft 14 and the interface region 11. The heavily doped p-type region 52 has been formed and silicon dioxide 54 and silicon nitride 56 layers have been deposited on wafer 46, as explained in connection with FIG. 3B-1. Next, silicon dioxide 54 and silicon nitride 56 layers are removed from interface region 11, where the CMOS devices will be fabricated. CMOS fabrication then commences using standard processes, and a p-type well 90, p-type layer 92, thick Si0 2 layer 94, and n-type layer 96 are formed by known methods. Polysilicon layer 58 (see FIG. 3B-1) is then deposited and polysilicon gates 98 are defined with the same masking operation which defines polysilicon resistors 62 (see FIG. 3C-1) . The resulting structure is as shown in FIG. 5B.
  • FIG. 5C shows PSG layer 66 and LTO layers 70 and 71, as in FIG. 3F-1.
  • Etch access holes 74 are formed and the PSG and LTO layers are etched to form microchannel 78, as explained in conjunction with FIG. 3H-1.
  • EDP etch pre-openings or windows 80 are formed as explained in connection with FIG. 3J-1, and the resulting structure is shown in FIG. 5D.
  • interface region 11 is masked so that the CMOS devices will not be affected.
  • CMOS device fabrication is completed when metal contacts 99 are formed which connect to p-type 92 and n-type 96 regions, as well known in the art.
  • the resulting structure is as shown in FIG. 5E.
  • the microneedle is then separated from the rest of the wafer, as explained in connection with FIGS. 3K-1 to 3L- 2.
  • the microneedle of the present invention can be expected to have broad applications to fluid sampling, fluid delivery, and precisely located chemical-reaction stimulation.
  • Microneedle 10 has successfully penetrated tissue without damage to the needle, due in part to the strong silicon backbone along the needle shaft. Since the microneedles have a thickness of approximately 70 ⁇ m (microchannel height, boron region plus single crystal region) over most of their length, they are relatively strong. Another advantage of the design of the microneedle is that during and after processing it is surrounded by regions of silicon having full wafer thickness, providing even greater strength, easy post processsing and handling.
  • FIG. 6 shows a real- time blood analysis system.
  • Tip 86 of microneedle 10 is inserted through tissue 100 into a blood vessel 102.
  • the blood is analyzed by an on-chip blood analysis amplifier and A/D converter 104, which converts an analog signal to a digital signal for digital output 106.
  • Digital output 106 is transmitted to a computer 108 for real-time computer analysis, and displayed, for example, on a cathode-ray tube. Since the diameter of shaft 14 is only approximately 50 ⁇ m, it causes minimal pain to the patient during penetration because there is little trauma to the tissue involved.
  • Another possible application of the silicon-processed microneedle is administration of drugs on a long term basis. For instance, the microneedle may be implanted in a small tumor and used to administer small, concentrated doses of a drug on an extremely local level.
  • microneedle 10 is inserted into neural tissue 110 such that tip region 86 is between adjacent cells 112.
  • recording sites or electrodes 84 on tip 86 detect the neural response to substance 114.
  • the recording sites passively detect a signal which is relayed to an amplifier 104, as discussed above. Since microneedle 10 is so small, the damage caused by penetrating brain tissue is reduced.
  • recording or electrode sites 84 provide the ability to obtain real-time neural measurements. Alternatively, recording sites 84 may be used to measure neural activities or to apply an electric field, current, charge or voltage to the tissue.
  • FIGS. 8A and 8B show alternative embodiments of a microneedle 120.
  • the microneedle may include two or more microchannels 122 and 124 so that two different fluids may be delivered via the shaft 14.
  • Microchannels 122 and 124 are formed on separate portions of a substrate, and there is no substrate between them.
  • electrodes 84 may be fabricated at the end of each channel to detect tissue response to chemical delivery.
  • Electronics 24 may be fabricated as necessary depending upon the number of channels, electrodes, etc.
  • shank end 12 may also include a network of channels 126 for distributing a fluid for analysis. Alternatively, if a number of fluids must be mixed just before delivery, it is possible to have them mix in channels 122 and 124.
  • Microneedle 10 has on-board resistive heaters 60 for bubble-pumping elements, fluid ports 18 for liquid/gas transport, and IC-interface region that can be used for future on-chip circuitry and microfluidic components.
  • the process for producing the needles is advantageous because the needles are surrounded by regions of silicon having full wafer thickness. This feature simplifies post- processing, handling, and lead attachment which can be accomplished prior to freeing the microneedle by breaking support beams.
  • the mask fabrication process is compatible with IC processes.
  • the microneedles are sufficiently sturdy to penetrate tissue without being damaged and without significant pain to the patient. Since the microneedle may be batch fabricated, the resulting microneedle is relatively inexpensive to produce as compared to a macroneedle.
  • the size of the shaft diameter may be readily controlled using known semiconductor fabrication techniques.

Abstract

This invention is an IC processed microneedle including an interface region (11), and a shaft (14). A shell defines an enclosed channel to form the shaft. The shaft has ports to permit fluid movement therethrough. Microheaters, microdetectors, and additional devices may also be fabricated on the microneedle.

Description

IC-PROCESSED MICRONEEDLES
BACKGROUND OF THE INVENTION The present invention relates generally to microneedles, and more particularly to microneedles fabricated by micromachining techniques.
As is well known, needles are used to extract samples of substances from living tissue in order to analyze the substances for diagnostic purposes, or to deliver a drug or a medicine. The majority of needles in use today are macroneedles, which have a relatively large diameter as compared to a blood cell and are on the order of millimeters (mm) . The large diameter of the macroneedle shaft has the disadvantage of possibly damaging biological tissue during penetration. Additionally, tissue penetration by the needle is often painful to the patient because of the relatively large needle diameter.
One type of spring-actuated macroneedle penetrates tissue and drops blood to a chemical detector for measurement. While this needle may be less painful to the patient because penetration is of a relatively short duration, the needle is still relatively large and may damage tissue. Additionally, neither of the above- mentioned macroneedles provide real-time blood analysis. As an alternative to macroneedles, microneedles having a diameter on the order of micrometers have many applications. For instance, they may be used as precise injection/extraction needles in cell biology, as injection/extraction heads in a drug delivery system or microchemical factory, and as injection/extraction heads in microsurgery. It is also advantageous to have a smaller size needle because the reduced size decreases discomfort and pain to the patient. This has been demonstrated in research on electrical microprobes made of silicon for an IC-co patible multichannel neural- recording array. The research has demonstrated that silicon microprobes with cross-sections on the order of tens of micrometers can penetrate living tissue without causing significant trauma. (K. Najafi, K.D. Wise and T. Mochizuki, "A High-Yield IC-Compatible Multichannel Recording Array," IEEE Micro Trans, on Electron Devices. vol. ED-32, pp. 1206-1211, July 1985.)
Recently, microneedles have been used with an inner diameter of approximately 20 micrometers (μm) (1 μm = 1 micron = 10"6m) . These microneedles are formed by heating the end of a glass pipette and lengthening the end until the diameter is reduced to about 20 μm. Most cells in an animal such as a human measure 10-20 micrometers in diameter. Thus, while these glass microneedles can be used to insert and withdraw fluids and gasses from a single cell, it is difficult to control the size of the needle shaft during fabrication. Additionally, the resulting needle is not very strong and real-time blood analysis is not possible. Another disadvantage of glass pipette needles is that it is difficult to incorporate electronics with such needles. In view of the foregoing, an object of the present invention is to provide a microneedle having controllable and relatively small dimensions, including shaft width, and a method for making the same.
Another object of the present invention is to provide a microneedle which permits real-time analysis of a fluid being sampled. Yet another object of the present invention is to provide a microneedle which minimizes the amount of trauma to the tissue being penetrated.
Still another object of the present invention is to provide a microneedle which may be mass produced.
Yet still another object of the present invention is to provide a microneedle which is strong enough to reliably penetrate biological tissue.
A further object of the present invention is to provide a microneedle which may incorporate micropumps, microvalves and microdetectors.
Additional objects and advantages of the invention will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by practice of the invention. The objects and advantages of the invention may be realized and obtained by means of the instrumentalities and combinations particularly pointed out in the claims.
SUMMARY OF THE INVENTION
The present invention is directed to an IC- processed microneedle formed from a substrate which defines an interface region and an elongated portion extending away from the interface region. A shaft is formed from the elongated region by a shell, which defines an enclosed channel within the shaft. One end of the shaft is attached to the interface region. The shaft includes ports which permit fluid to flow through the microneedle. The method of the present invention includes a sequence of steps for forming an IC-processed microneedle. First, a substrate is provided for forming an interface region and an elongated portion extending away from the interface region. A patterned non-planar etchable structure is then formed on the frontside of the elongated portion of the substrate. An unetchable membrane layer is deposited atop the etchable structure, and etching holes are opened in the membrane layer. One of the etching holes is at an end of the membrane layer and a second etching hole is positioned at a second end of the membrane layer. Next, the etchable structure is etched to a predetermined extent to form a cavity underneath the membrane layer, thereby producing a shaft formed from the membrane layer and the elongated portion of said substrate.
BRIEF DESCRIPTION OF THE DRAWINGS
The accompanying drawings, which are incorporated in and constitute a part of the specification, schematically illustrate a preferred embodiment of the invention and, together with the general description given above and the detailed description of the preferred embodiment given below, serve to explain the principles of the invention.
Figure 1A is a perspective view of an embodiment of a silicon processed microneedle. Figure IB is a cross-sectional view of the microneedle as taken along line IB-IB of Figure 1A.
Figure IC is a cross-sectional view of the microneedle as taken along line 1C-1C of Figure 1A.
Figure 2A is a plan view of the microneedle prior to detachment from the substrate.
Figure 2B is a cross-sectional view of the microneedle as taken along line 2B-2B of Figure 2A.
Figures 3A-1 to 3N-2 schematically illustrate a microneedle fabrication process according to the present invention. The left-hand figures are taken along line 3L-3L of Figure 1A, and the right-hand figures are taken along line 3R-3R.
Figures 4A and 4B are views illustrating a icroheater and its positioning relative to the microchannel, respectively. Figures 5A-5E show the sequence of steps in fabricating the microneedle with on-chip CMOS (complementary metal-oxide semiconductor) as taken along line 5-5 of Figure lA. Figure 6 is a schematic diagram showing the microneedle penetrating tissue in a first application of the present invention.
Figure 7 is a schematic diagram including a detailed portion showing the microneedle penetrating tissue in another application of microneedle use.
Figures 8A and 8B show alternative embodiments of the microneedle.
DESCRIPTION OF THE PREFERRED EMBODIMENT The present invention will be described in terms of the preferred embodiment. The preferred embodiment is an apparatus and method for fabricating IC-processed microneedles. Referring in detail to th- drawings, wherein like reference numerals designate like parts in several figures, and initially to FIG. 1A, a microneedle 10 in accordance with the present invention is illustrated.
Microneedle 10 includes an interface region 11 and a shaft 14 having a icroflow channel 78 therein along its length. A distal end 20 of shaft 14 can be inserted into tissue (not shown) so that liquids
(including gases) may be delivered to or taken from a patient, for example, via a distal fluid port 18. A shank fluid port 22 is located on shank or proximal end 12 of shaft 14 to deliver or receive fluids. The microneedle may include more than two ports, as desired. Microflow channel 78 runs along the length of fully- enclosed microneedle shaft 14. A series of thin polysilicon heating resistors 60 are located on interface region 11 along the floor of microflow channel 78. Interface region 11 is sufficiently thick to permit incorporation of on-chip electronics 24 for real-time fluid analysis. Heating resistors 60 may be used to form a thermally-driven, cascaded-bubble icropump or simple heater. The microneedle may also include detector resistors 62 which extend along the bottom of the icrochannel (see FIG. IB) and are coupled to electrodes 84 (FIG. 3L-2) on the tip 86 of the needle. Microflow channel 78 is formed by removing sacrificial layers from underneath a shell 26 during processing. In order to access the sacrificial layer, etch access holes 74 are opened and then filled after etching. The fabrication procedures will be discussed below in . relation to FIGS. 3A-1 through 3N-2.
FIG. IB shows a cross-section of fully-enclosed microflow channel 78. The channel height is approximately 9 μm, and is indicated by dimension "G" , and the channel width "H" may be between 30 μm to 60 μm. The needle height "I" is about 70 μm, and the needle width "J" is approximately 80 μm at the tip region. FIG. IC illustrates the positioning of a polysilicon resistor 60 on interface region 11. Contact pads 36 are situated on both sides of the microflow channel 78 at shank end 12 and provide an outside connection to resistors 60, which function as microheaters. Note that detector resistors 62 cannot be seen in FIG. IC because this cross-section is taken along line 1C-1C on the interface region. The detector resistors extend along the length of the channel but do not extend into the interface region any further than is necessary to couple them to electronics 24. The location of both resistors can be best seen in FIG. 3N- 2.
FIG. 2A is a plan view of a microneedle 10 before it is separated from wafer or substrate 46 by breaking beams 44. Support beams 44 connect microneedle 10 to substrate 46 and facilitate testing and manipulation of the microneedle prior to its final use. Although only a single microneedle 10 is shown, many microneedles may be fabricated on a single wafer. Area 40 marks the area where microneedle 10 will be separated from substrate or thin-film 46. Interface region 11 may be used as an integrated-circuit (IC) interface region of approximately 2 to 3 millimeters (mm)2. The tip region 86 is formed at an angle θ of approximately 45° to the plane of the needle shaft 14, to form a sharp triangular tip 87. The width of the interface region, indicated by dimension "X", is approximately 1.5 mm, and the length of the shaft, indicated by dimension "Y", is between 1 and 6 mm. At shank end 12, interface region 11 widens out to a large surface area, suitable for incorporation of additional integrated electronic and/or fluidic devices. Cross-sectional dimensions of a completed microneedle 10 are shown in FIG. 2B after if has been detached from wafer 46. Wafer 46 has an initial thickness of between 500 and 550 μm, as indicated by "Z". The wafer thickness of the microneedle is reduced during fabrication. Shaft 14 has a thickness of approximately 50 μm indicated by dimension "I". In microneedles which are 3 mm-long or longer, microneedle 10 tapers from the tip end 86, where it is approximately 80 μm wide, to 140 μm, where it joins the shank in order to increase strength. The retained single-crystal silicon layer 46 provides a rigid spine which adds strength to the needle. Note that there is no single- crystal silicon at the tip region 86, so that the tip is sharper and smaller than the portion of the shaft including single-crystal silicon.
The fabrication sequence for formation of a microneedle is shown in FIGS. 3A-1 to 3N-2. Seven masks may be used. The drawings are not to scale, and dimensions should be taken from the text; the drawings are to illustrate the process, and not necessarily the preferred dimensions of the microneedle. The microneedle is formed using IC (integrated circuit) processing methods, e.g. oxidation, lithography, chemical vapor deposition, doping, and etching. Briefly, microchannel 78 is surface-micro achined onto a single-crystal silicon substrate or thin-film 46 that is mostly etched from the wafer backside along shaft 14 in the final fabrication step. While only a single microneedle is shown in the following steps, it will be understood that many microneedles may be fabricated simultaneously on a single wafer. FIGS. 3A-1 AND 3A-2 show a <100>-oriented lightly doped n-type silicon wafer 46 which is 500-550 μm thick. A thick masking layer 47 of silicon dioxide (Si02) 1.2 μm thick is thermally grown on wafer frontside 48 and backside 50. Masking layer 47 is patterned as shown, and boron is diffused at approximately 1125 °C for fifteen hours to form a 12 μm-deep heavily doped p-type region 52. Both the future interface region 11 and shaft 14 are indicated generally in these figures. Boron-doped region 52 defines tip region 84 (FIG. 2A) , extends along the needle shaft and defines the perimeter of interface region 11, as best shown in FIG. 2A. Boron-doped region 52 acts as an etchant stop since EDP (ethyleneidamine pyrocatacol and water) , used during fabrication, does not etch boron-doped silicon. Note that the boron-doped region is omitted from the center of IC interface region 11 because, as well known, any electronic components incorporated into the microneedle must be atop undoped silicon.
Masking layer 47 is then removed, and a 400 nanometer (nm) thick layer 54 of Si02 is thermally grown on the wafer. A 600 nm low-stress nitride layer 56 is then deposited by low pressure chemical vapor deposition (LPCVD) for passivation. As well known, CVD will deposit on all exposed surfaces of the wafer. Silicon dioxide layer 54 will serve as a thermal barrier underneath the microheater as well as an electronic insulation layer. Silicon nitride layer 56 serves as the bottom layer of the microchannel. Next, a 600 nm- thick LPCVD phosphorus-doped polycrystalline silicon layer 58 is then deposited, and the resulting structure is as shown in FIGS. 3B-1 and 3B-2. Polysilicon layer 58 is patterned and etched to define polysilicon heating resistors 60 on interface region 11 (FIG. 3C-1) and, if desired, polysilicon detector resistors 62 (FIG. 3C-2) . Note that phosphorus-doped polycrystalline silicon layer 58 is also etched away on backside 50. Resistors 60 are shown perpendicular to the length of channel 78; however, they may also be fabricated such that they extend lengthwise parallel to channel 78 or in any other orientation under the area of fluid flow. Resistors 60 are approximately 50 μm long. Detector resistors 62 extend lengthwise along shaft 14 and function as wires to relay a signal from electrodes or recording sites 84 (FIG. 2A) to the shank end of the channel, where electronics 24 process the signals. There is one resistor for each electrode and so the width of channel 78 determines the number of electrodes which may be fabricated within the channel. The microneedle shown has two resistors, but more electrodes could be incorporated into the microneedle by widening the channel or altering the aspect ratio of the resistors. Both heating resistors 60 and detector resistors 62 are approximately .5 μm high, and 2 μm wide. Heating resistors 60 are approximately 50 μm long. The length of detector resistors 62 depends upon the eventual length of shaft 14. However, resistors 62 should reach the tip of the needle so that electrodes or recording sites may also be at the needle tip 86.
Referring now to FIGS. 3D-1 and 3D-2, a thin layer 64 of approximately 150 nm of LPCVD low-stress nitride is deposited to cover and protect polysilicon resistors 60 and 62 during subsequent EDP
(ethyleneidamine pyrocatacol and water) etching. A layer 66 of 5 μm phosphosilicate glass (PSG) is deposited by LPCVD process and then an approximately 3 μm layer 68 of a low-temperature oxide (LTO) such as undoped LPCVD Si02 is deposited. The LTO layer on top of the PSG gives better adhesion to photoresist. The LTO layer also desirably minimizes hydrofluoric acid
(HF) attack on the interface between the photoresist and PSG. Furthermore, no high-temperature densification process is needed so that the future circuitry in the IC interface region 11 will not be damaged. The microflow channel is then patterned and wet- etched in a 5:1 solution of buffered HF, as shown in FIGS. 3E-1 AND 3E-2. The buffered HF etches both PSG 66 and LTO 68 layers as shown. The primary configuration of the channel is formed by this etch. A .5 μm LTO layer 71 (FIGS. 3F-1 and 3F-2) is then deposited by
LPCVD to provide an area for future etch access holes. The resulting shell formed from LTO layers 68 and 71 is approximately 3-4 μm. LTO layer 71 is then patterned and wet-etched in 5:1 BHF (buffered hydrofluoric acid) to provide an etch channels area 70 as shown in FIG. 3F- 1. Dry-etching is also possible for this step. LTO layer 71 is also deposited on backside 50, but is not shown because they it is removed after the BHF wet-etch. The etch channels area 70 is advantageously only about .5 μm thick because it will be relatively easy to fill etch holes later in the fabrication process, as will become apparent below.
The wafer is then coated with a 1 μm thick layer 72 of LPCVD low-stress silicon nitride which will become a portion of the microchannel shell 26 (FIG. IB) . Etch access holes 74 and distal 18 and shank 22 fluid ports are defined and etched in a plasma etcher through silicon nitride layer 72. The etch access holes lead to the sacrificial PSG and LTO layers which will be etched. The cross-section appears as in FIG. 3G-1; the etch access holes are not visible in FIG. 3G-2. Etch access holes are formed along the length of the shaft 14 in etch channel area 70, and are located every 25 μm. The duration of the sacrificial-layer etching step is thus independent of channel length. The etch access holes are approximately 5μm x 5μm. Fluid ports 18 and 22 will permit flow of a liquid through the microchannel 78 when the needle is fully operational. The fluid ports are approximately 20 μm x 20 μm. In a preferred embodiment, distal fluid port 18 is positioned 150 μm up the microneedle from the tip 86. Since the PSG and LTO layers are underneath nitride layer 72,. resistors 60 and 62 will not be affected by this etch. Additionally, because the fluid ports are relatively large as compared to the etch access holes, the fluid ports will not be completely filled during deposition of silicon nitride sealing layer 76, in which etch access holes are sealed (described below) . As an alternative, the fluid ports may be etched after the sacrificial PSG and LTO layers are removed from within the microchannel if good process control is employed. However, this method has the possible drawback of affecting silicon nitride 64, which protects resistors 60 and 62. Since layer 64 is approximately 150 nm, the resistors will not be affected because the etch will remove about 50 nm of layer 64. As another alternative, resistors 60 and 62 may be located so that they will not be underneath the fluid ports.
After the etch access holes and fluid ports have been formed, the wafer is immersed in concentrated hydrofluoric acid (48% HF) for approximately 2.5 minutes to remove PSG layer 66, and LTO layers 68 and 71 underneath nitride shell 72. Wafer 46 is then rinsed in de-ionized water, snd any residual oxide is removed from the silicon nitride 72 using HF. The resulting microneedle is then as shown in FIGS. 3H-1 and 3H-2.
All etch access holes 74 are sealed by deposition of an additional 1.5 μm thick layer 76 of LPCVD low- stress nitride to form a shell 26, as shown in FIGS. 31- 1 and 31-2. Since the thickness of the PSG before etching was only about .5 μm underneath the etch access holes 74, a 1.5 μm deposition of silicon nitride insures that the hole will be completely filled. Microchannel 78 is thus completely sealed, except for the fluid ports. Fluid ports 18 and 22 are sufficiently wide that they will not be sealed by deposition of the 1.5 μm silicon nitride sealing layer. The size of the fluid ports is somewhat reduced during this step, but they remain sufficiently large enough to permit adequate fluid flow. A thin layer 76 of silicon nitride is also deposited in channel 78, as shown.
It is possible to form channel 78 without including etch access holes 74 by using the fluid ports to remove the sacrificial PSG and LTO layers. However, this approach would require more time to fully evacuate the channel. A clear advantage would be that the previous sealing step could be omitted. The needle has now been substantially fabricated, and steps to separate it from the wafer are now taken. EDP etch pre-openings or windows 80 are patterned by a mask and plasma etched in order to facilitate final separation of microneedle 10 from the rest of the wafer, as shown in FIGS. 3J-1 and 3J-2. Etch windows 80 are stopped at the 400 nm-thick Si02 layer 54. The etch windows will facilitate removal of the microneedle from the wafer during subsequent backside etch. It will be desirable later to remove both layers 54 and 56 in order to separate the microneedle. However, the etch is stopped at layer 54 at this point because it is relatively easy to etch silicon dioxide and relatively difficult to etch silicon nitride. Thus, silicon nitride layer 56 is removed from the frontside prior to backside etching.
Next, an electrode hole 82 is formed by patterning and plasma-etching down to the 600 nm-thick phosphorus-doped polycrystalline silicon layer 58 to permit electrical contact with resistors 62. Only a single electrode hole 82 is shown in FIG. 3K-2 (the electrode is not visible in FIG. 3K-1) , but the process for fabricating contact pads 36 (see FIG. IC) is identical and is performed at the same time as electrode fabrication. The electrodes function as recording sites at distal end 20 and permit monitoring of biological electrical activity, as will be discussed below. The contact pads permit coupling of electronics with heating resistors 62. After electrode hole 82 is formed, a thin layer of titanium is deposited, followed by a thicker layer of platinum which completely fills the hole, forming a complete electrode 84 as shown in FIG. 3L-1. Again, the electrode is not visible in FIG. 3L-2.
At this point, microneedle 10 is essentially complete and must now be partially separated from wafer 46. The backside of the wafer is patterned with a blank mask and without alignment to open the etching areas of individual die to free the microneedles from the wafer backside. In a preferred fabrication method, the mask is positioned so that the microneedle tip extends to the blank center of the mask. Shank end 12 is covered by the mask and is not etched, but distal end 18 is not covered by the mask and so end 18 is completely etched. A timed EDP etch reduces the silicon wafer thickness to 120 μm, as shown in FIGS. 3M-1 and 3M-2. After rinsing in de-ionized water, the wafer is immersed in a 5:1 BHF solution which attacks only the pre-opened, bare Si02 layer 54. Pre-EDP etch window 80 is thus deepened so that it extends to undoped silicon layer 46.
Immersion in an EDP timed etch reduces the 120 μm thickness to 50 μm at shank end 12 as shown in FIGS. 3N- 1 and 3N-2. As also shown in FIG. 2B, tip region 86 of shaft 14 does not contain any single-crystal silicon due to the corner-etching behavior of EDP. A combination of corner etching and etching from the crystal backside also removes the thicker non-doped single-crystal silicon for approximately 50 μm along the needle underside from the tip end. The corner etching behavior of EDP is addressed by B. Bassous in "Fabrication of Novel Three-Dimensional Microstructures by the
Anisotropic Etching of (100) and (110) Silicon, ", IEEE Trans, on Electron Devices. Vol. Ed-25, No. 10, Oct. 1978.
The microneedle is then partially separated from the wafer, and remains attached through support beams 44, best shown in FIG. 2A. Since the many microneedles fabricated on wafer remain attached to the wafer, it is easier to package, transport, and handle the needles than if they were fully freed by the anisotropic etch. When a free-standing microneedle is desired, the microneedle is simply detached from the rest of the wafer by using, for example, tweezers or some other similar implement to apply pressure to beams 44. When the beams are broken, the microneedle is freed from the wafer.
FIG. 4A shows a simplified view of resistor 60 and contact pads 36 (also FIG. IC) of microneedle 10 (not shown) . As explained above, the contact pads and resistor are defined on a single-doped polysilicon layer. A silicon dioxide layer 54 separates silicon substrate 46 and the contact pads and resistor. Resistor 60 functions as a microheater when a voltage source 30 supplies current to contact pads 36. The resistors propel a liquid to distal fluid port 18, as explained below. FIG. 4B illustrates the positioning of microneedle shell 26 above resistors 60. As noted above, since there is a silicon dioxide layer 54 underneath the polysilicon heater, heat conduction from the heater to silicon substrate 46 is restricted because Si02 layer 54 acts as an insulator. Due to the low power dissipated in the heater, the temperature of undoped silicon substrate 46 remains at the ambient temperature. The heaters are especially advantageous if a chemical reaction occurs quickly in response to heat. The reaction may occur in the microneedle and then may be quickly delivered to the appropriate tissue. A single resistor is shown in FIGS. 4A and 4B to illustrate its positioning. However, in a preferred embodiment five resistors 60 form a thermally-driven cascaded bubble pump (FIG. 2A) . In operation, the resistor furthest from the needle tip is heated and produces a single vapor bubble. Then, the adjacent resistor is heated and the bubble is moved sequentially down the line of resistors toward the distal end of the needle shaft. The resistors are heated quickly and sequentially, so that precise fluid control is possible. If a cascaded bubble pump is not employed, a fluid may move down the needle shaft simply by means of gravity.
In addition to resistors, micropumps and microvalves (neither is shown) may be incorporated onto the microneedle. For example, the resistors may also be part of a bubble-powered micropump coupled to an actuator. As discussed above, the bubble generation system creates individual, spherical vapor bubbles from 2 to 500 μm in diameter by locally heating a fluid with a thin film resistor. Prior research has shown that microbubbles are capable of actuating a polycrystalline silicon cantilever (See L. Lin and A.P. Pisano, "Bubble Forming on a Micro Line Heater", Proceedings of ASME Winter Annual Meeting. Micromechanical Sensors. Actuators and Systems. DSC-Vol. 32, pp. 147-163, 1991). Other micropumps can also be employed with these microneedles, such as those actuated by ultrasonic Lamb waves (See R.M. Moroney, R.M. White and R.T. Howe, "Microtransport Induced by Ultrasonic Lamb Waves," Applied Physics letters, pp. 774-776, V59, August, 1991); piezoelectrics (See H.T.G. Van Lintel, F.C.M. Van Deol and S. Bouwstra, "A Piezoelectric Micropump Based on Micromachining of Silicon," Sensors and Actuators. Vol. 15, pp. 153-157, 1988, and M. Esashi, S. Shoji and A. Nakano, "Normally Closed Microvalve and Micropump Fabricated on a Silicon Wafer," Sensors and Actuators. Vol. 20, pp. 163-169, Nov. 1989); and electrohydrodynamics (See S. F. Bart, L. S. Tavrow, M. Mehregany and J. H. Lang, "Microfabricated Electrohydrodynamic Pumps," Sensors and Actuators, Vol. 21, Nl-3, pp. 193-197, Feb. 1990).
FIGS. 5A-5E briefly illustrate a process for fabricating a microneedle with on-chip CMOS
(complementary metal-oxide semiconductor) devices. Both CMOS and BiCMOS are compatible with the microneedle fabrication process. The anufacturability of an on- chip electronic interface with the microneedle is essential for a broad range of applications. The manufacturabilities of the on-chip CMOS and bipolar CMOS devices with the IC-processed microneedle increase the signal conditioning ability, which is not a possible feature in needles fabricated by other means. Formation of the microneedle itself is via the same steps illustrated in FIGS. 3A-1 to 3N-2, and the CMOS devices are fabricated using standard processes. FIGS. 5A-5E, illustrate the best mode sequence for integrating fabrication of both the microneedle and CMOS devices. FIGS. 5A-5E are taken along line 5-5 of FIG. 1A, although no CMOS devices are shown in FIG. 1A. FIG. 5A is a cross-sectional view of the partially constructed needle shaft 14 and the interface region 11. The heavily doped p-type region 52 has been formed and silicon dioxide 54 and silicon nitride 56 layers have been deposited on wafer 46, as explained in connection with FIG. 3B-1. Next, silicon dioxide 54 and silicon nitride 56 layers are removed from interface region 11, where the CMOS devices will be fabricated. CMOS fabrication then commences using standard processes, and a p-type well 90, p-type layer 92, thick Si02 layer 94, and n-type layer 96 are formed by known methods. Polysilicon layer 58 (see FIG. 3B-1) is then deposited and polysilicon gates 98 are defined with the same masking operation which defines polysilicon resistors 62 (see FIG. 3C-1) . The resulting structure is as shown in FIG. 5B.
FIG. 5C shows PSG layer 66 and LTO layers 70 and 71, as in FIG. 3F-1. Etch access holes 74 are formed and the PSG and LTO layers are etched to form microchannel 78, as explained in conjunction with FIG. 3H-1. EDP etch pre-openings or windows 80 are formed as explained in connection with FIG. 3J-1, and the resulting structure is shown in FIG. 5D. During these operations, interface region 11 is masked so that the CMOS devices will not be affected. Next, CMOS device fabrication is completed when metal contacts 99 are formed which connect to p-type 92 and n-type 96 regions, as well known in the art. The resulting structure is as shown in FIG. 5E. The microneedle is then separated from the rest of the wafer, as explained in connection with FIGS. 3K-1 to 3L- 2.
The microneedle of the present invention can be expected to have broad applications to fluid sampling, fluid delivery, and precisely located chemical-reaction stimulation. Microneedle 10 has successfully penetrated tissue without damage to the needle, due in part to the strong silicon backbone along the needle shaft. Since the microneedles have a thickness of approximately 70 μm (microchannel height, boron region plus single crystal region) over most of their length, they are relatively strong. Another advantage of the design of the microneedle is that during and after processing it is surrounded by regions of silicon having full wafer thickness, providing even greater strength, easy post processsing and handling.
An application of the microneedle of the present invention is illustrated in FIG. 6, which shows a real- time blood analysis system. Tip 86 of microneedle 10 is inserted through tissue 100 into a blood vessel 102. As blood is drawn into the needle via shaft 14, the blood is analyzed by an on-chip blood analysis amplifier and A/D converter 104, which converts an analog signal to a digital signal for digital output 106. Digital output 106 is transmitted to a computer 108 for real-time computer analysis, and displayed, for example, on a cathode-ray tube. Since the diameter of shaft 14 is only approximately 50 μm, it causes minimal pain to the patient during penetration because there is little trauma to the tissue involved. Another possible application of the silicon-processed microneedle is administration of drugs on a long term basis. For instance, the microneedle may be implanted in a small tumor and used to administer small, concentrated doses of a drug on an extremely local level.
Another application of the microneedle is shown in FIG. 7, in which the microneedle is used for recording neural signals. Specifically, microneedle 10 is inserted into neural tissue 110 such that tip region 86 is between adjacent cells 112. As a chemical substance 114 is delivered to neural tissue 110, recording sites or electrodes 84 on tip 86 detect the neural response to substance 114. The recording sites passively detect a signal which is relayed to an amplifier 104, as discussed above. Since microneedle 10 is so small, the damage caused by penetrating brain tissue is reduced. Additionally, recording or electrode sites 84 provide the ability to obtain real-time neural measurements. Alternatively, recording sites 84 may be used to measure neural activities or to apply an electric field, current, charge or voltage to the tissue. Processing electronics may be located separate from the interface region, as desired. Additionally, an active device may be positioned at the tip of the microneedle to process a detected signal. FIGS. 8A and 8B show alternative embodiments of a microneedle 120. The microneedle may include two or more microchannels 122 and 124 so that two different fluids may be delivered via the shaft 14. Microchannels 122 and 124 are formed on separate portions of a substrate, and there is no substrate between them. Additionally, electrodes 84 may be fabricated at the end of each channel to detect tissue response to chemical delivery. Electronics 24 may be fabricated as necessary depending upon the number of channels, electrodes, etc. As shown in FIG. 8B, shank end 12 may also include a network of channels 126 for distributing a fluid for analysis. Alternatively, if a number of fluids must be mixed just before delivery, it is possible to have them mix in channels 122 and 124.
In summary, an apparatus and method for a IC- processed microneedle have been described. Microneedle 10 has on-board resistive heaters 60 for bubble-pumping elements, fluid ports 18 for liquid/gas transport, and IC-interface region that can be used for future on-chip circuitry and microfluidic components. The process for producing the needles is advantageous because the needles are surrounded by regions of silicon having full wafer thickness. This feature simplifies post- processing, handling, and lead attachment which can be accomplished prior to freeing the microneedle by breaking support beams. The mask fabrication process is compatible with IC processes. The microneedles are sufficiently sturdy to penetrate tissue without being damaged and without significant pain to the patient. Since the microneedle may be batch fabricated, the resulting microneedle is relatively inexpensive to produce as compared to a macroneedle. The size of the shaft diameter may be readily controlled using known semiconductor fabrication techniques.
The present invention has been described in terms of a preferred embodiment. The invention, however, is not limited to the embodiment depicted and described. Rather, the scope of the invention is defined by the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A icrostructure, comprising: a substrate; and a shell defining an enclosed channel above said substrate to form a shaft.
2. The microstructure of claim 1 wherein: said substrate defines an interface region and an elongated portion extending away from said interface region; and said shaft includes a first end at said interface region, a second end distal from said first end, and at least two ports for permitting movement of a fluid therethrough.
3. The microstructure of claim 2 further including: heating means at said first end of said shaft for heating a liquid within said shaft, whereby said liquid forms a bubble and moves within said shaft.
4. The microstructure of claim 3 wherein said heating means comprises a polysilicon resistor.
5. The microstructure of claim 2 further including: detecting means on said elongated portion for monitoring electrical activity generated by biological tissue in which said microstructure is inserted.
6. The microstructure of claim 5 wherein said detecting means is located at said second end of said shaft.
7. The microstructure of claim 5 wherein said detecting means includes: a polysilicon resistor.
8. The microstructure of claim 2 further including fluid movement means for moving a fluid along said shaft.
9. The microstructure of claim 8 wherein said fluid movement means includes: a plurality of resistors fabricated proximate each another, wherein when said resistors are heated in sequence, a vapor bubble produced is moved sequentially along said resistors.
10. The microstructure of claim 9 wherein said plurality of resistors are positioned in a line.
11. The microstructure of claim 2 wherein a first of said at least two ports is located at said first end of said shaft and a second of said at least two ports is located at said second end of said shaft.
12. The microstructure of claim 2 further including electronic components fabricated on said interface region.
13. The microstructure of claim 2 further including a plurality of end channels converging at said first end and communicating with said enclosed channel.
14. The microstructure of claim 2 wherein its elements are formed by integrated-circuit microfabrication methods.
15. An microneedle, comprising: an interface region having an area of 2 to 3 millimeters square; and an elongated hollow shaft connected to and extending from said interface region for permitting movement of a fluid therethrough, said shaft having a length of between about 1 and 6 millimeters, said shaft having at a distal end a width of about 50 micrometers or less and a height of about 9 micrometers or less.
16. The microneedle of claim 15 further including at least one resistor located within said shaft for heating a fluid to form a bubble that moves along said shaft.
17. A method of fabricating a microstructure, comprising the steps of: providing a substrate for forming an interface region and an elongated portion extending away from said interface region, said substrate including a frontside and a backside; forming a patterned, non-planar etchable structure on the frontside of said elongated portion; depositing an unetchable membrane layer atop said etchable structure; opening at least one etching hole in said membrane layer; and etching said etchable structure by placing an etchant into said etching hole, said etchable structure being etched to a predetermined extent to form a cavity underneath said membrane layer, thereby producing a shaft formed from said membrane layer and said elongated portion of said substrate.
18. The method of claim 17 further including the step of: depositing additional membrane material to close said at least one etching hole.
19. The method of claim 17 wherein said opening step includes opening a plurality of etching holes including a first etching hole at a first end of said membrane layer and a second etching hole at a second end of said membrane layer
20. The method of claim 19 wherein said depositing step includes: depositing additional membrane material to close said plurality of etching holes except said first and second etching holes, which form ports for permitting flow of a liquid therethrough.
21. The method of claim 17 further including the step of: prior to said step of forming said patterned non- planar etchable structure, forming at least one polysilicon resistor, such that said patterned non- planar etchable structure is then deposited atop said resistor.
22. The microstructure fabricated by the method of claim 17.
23. The method of claim 17 further including the steps of: patterning the backside of said substrate; and etching the backside in order to separate said shaft and said interface region from said substrate.
24. The method of claim 23 wherein said backside etching step further includes the steps of : etching the backside to a predetermined extent such that said interface region and said elongated portion remain attached to said substrate; etching portions of thin films on the frontside of said substrate to form an opening through to said substrate; and etching said substrate such that said opening extends through said substrate on said elongated portion, said elongated portion being detached from said substrate.
25. A method of fabricating a microneedle, comprising the steps of: providing a semiconductor substrate for forming an interface region and an elongated portion; forming a shaft enclosing a microchannel along said elongated portion, said shaft extending from said interface region; and forming first and second ports through said shaft for permitting transport of liquids through said microchannel.
26. The method of claim 25 further including the step of: providing a first resistor on said substrate within said shaft for heating liquids which flow therethrough.
27. The method of claim 26 further including the step of: fabricating a CMOS device on said interface region.
28. The method of claim 27 wherein said CMOS fabricating step includes depositing a polysilicon layer, said polysilicon layer also forming said first resistor.
PCT/US1995/007916 1994-06-06 1995-06-06 Ic-processed microneedles WO1995033504A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU29072/95A AU2907295A (en) 1994-06-06 1995-06-06 Ic-processed microneedles

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/254,328 1994-06-06
US08/254,328 US5591139A (en) 1994-06-06 1994-06-06 IC-processed microneedles

Publications (1)

Publication Number Publication Date
WO1995033504A1 true WO1995033504A1 (en) 1995-12-14

Family

ID=22963860

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1995/007916 WO1995033504A1 (en) 1994-06-06 1995-06-06 Ic-processed microneedles

Country Status (3)

Country Link
US (2) US5591139A (en)
AU (1) AU2907295A (en)
WO (1) WO1995033504A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999041606A1 (en) * 1998-02-16 1999-08-19 Stichting Voor Fundamenteel Onderzoek Der Materie Microdialysis-probe integrated with a si-chip
WO2002049507A1 (en) 2000-12-19 2002-06-27 Inverness Medical Limited Analyte measurement
EP1267159A2 (en) * 2001-06-11 2002-12-18 Bayer Corporation Electrochemical sensor and method of making
EP1911394A1 (en) * 2006-10-14 2008-04-16 Roche Diagnostics GmbH Lancet with capillar channel
EP1967581A1 (en) * 2007-03-08 2008-09-10 Interuniversitair Microelektronica Centrum CMOS compatible microneedle structures
US8298487B2 (en) 2000-12-12 2012-10-30 Bayer Healthcare Llc Method of forming an electrochemical sensor
EP2708889A1 (en) * 2012-09-12 2014-03-19 Universität Leipzig Method and device for obtaining a tissue sample and for characterizing the tissue sample by determining at least one electrical property
US9551698B2 (en) 2009-12-30 2017-01-24 Imec Microneedle

Families Citing this family (380)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007676A (en) * 1992-09-29 1999-12-28 Boehringer Ingelheim International Gmbh Atomizing nozzle and filter and spray generating device
US7235056B2 (en) * 1996-05-17 2007-06-26 Amira Medical Body fluid sampling device and methods of use
US7828749B2 (en) 1996-05-17 2010-11-09 Roche Diagnostics Operations, Inc. Blood and interstitial fluid sampling device
US7666150B2 (en) * 1996-05-17 2010-02-23 Roche Diagnostics Operations, Inc. Blood and interstitial fluid sampling device
EP1579814A3 (en) 1996-05-17 2006-06-14 Roche Diagnostics Operations, Inc. Methods and apparatus for sampling and analyzing body fluid
US20020010406A1 (en) * 1996-05-17 2002-01-24 Douglas Joel S. Methods and apparatus for expressing body fluid from an incision
KR100232998B1 (en) * 1996-06-05 1999-12-01 윤종용 Chemical bath unit with controlling means for etch rate
DE69823904T2 (en) * 1997-03-20 2005-06-16 F. Hoffmann-La Roche Ag Micromechanical pipetting device
US5928207A (en) * 1997-06-30 1999-07-27 The Regents Of The University Of California Microneedle with isotropically etched tip, and method of fabricating such a device
DE19742439C1 (en) * 1997-09-26 1998-10-22 Boehringer Ingelheim Int Fluid micro-filter
US6036924A (en) * 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6106751A (en) 1998-03-18 2000-08-22 The Regents Of The University Of California Method for fabricating needles via conformal deposition in two-piece molds
US6391005B1 (en) * 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
AU2004200303B2 (en) * 1998-06-10 2007-10-18 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
EP1086214B1 (en) * 1998-06-10 2009-11-25 Georgia Tech Research Corporation Microneedle devices and methods of their manufacture
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
GB9815819D0 (en) * 1998-07-22 1998-09-16 Secr Defence Transferring materials into cells and a microneedle array
GB9815820D0 (en) * 1998-07-22 1998-09-16 Secr Defence Improvements relating to micro-machining
US6100107A (en) * 1998-08-06 2000-08-08 Industrial Technology Research Institute Microchannel-element assembly and preparation method thereof
US6010461A (en) * 1998-09-01 2000-01-04 Sitek, Inc. Monolithic silicon intra-ocular pressure sensor and method therefor
CA2344398A1 (en) * 1998-09-18 2000-03-30 The University Of Utah Surface micromachined microneedles
US7048723B1 (en) 1998-09-18 2006-05-23 The University Of Utah Research Foundation Surface micromachined microneedles
WO2000042233A1 (en) * 1999-01-13 2000-07-20 Cornell Research Foundation, Inc. Monolithic fabrication of fluidic structures
US6314317B1 (en) * 1999-02-18 2001-11-06 Biovalve Technologies, Inc. Electroactive pore
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6312612B1 (en) 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6379324B1 (en) 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US6835184B1 (en) 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US20020156453A1 (en) * 1999-10-14 2002-10-24 Pettis Ronald J. Method and device for reducing therapeutic dosage
US20020095134A1 (en) * 1999-10-14 2002-07-18 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
AU2573801A (en) 1999-11-02 2001-05-14 University Of Hawaii Method for fabricating arrays of micro-needles
ES2248165T3 (en) * 1999-11-15 2006-03-16 Velcro Industries B.V. SKIN FIXING ELEMENT.
US6511463B1 (en) 1999-11-18 2003-01-28 Jds Uniphase Corporation Methods of fabricating microneedle arrays using sacrificial molds
US20030168396A1 (en) * 1999-12-08 2003-09-11 Jacobson James D. Monolithic filter body and fabrication technique
ATE523239T1 (en) * 1999-12-08 2011-09-15 Baxter Int METHOD FOR PRODUCING MICROPOROUS FILTER MEMBRANES
US6982058B2 (en) * 1999-12-08 2006-01-03 Baxter International, Inc. Method for fabricating three dimensional structures
US7427526B2 (en) * 1999-12-20 2008-09-23 The Penn State Research Foundation Deposited thin films and their use in separation and sacrificial layer applications
US6375627B1 (en) 2000-03-02 2002-04-23 Agilent Technologies, Inc. Physiological fluid extraction with rapid analysis
DE10010587A1 (en) 2000-03-03 2001-09-06 Roche Diagnostics Gmbh System for the determination of analyte concentrations in body fluids
DE10010694A1 (en) * 2000-03-04 2001-09-06 Roche Diagnostics Gmbh Lancet including tipped needle with body surrounding tip
AU2001245472A1 (en) * 2000-03-09 2001-09-17 Nanopass Ltd. Systems and methods for the transport of fluids through a biological barrier andproduction techniques for such systems
EP1280617A4 (en) * 2000-04-17 2005-08-03 Penn State Res Found Deposited thin films and their use in separation and sarcrificial layer applications
US6595947B1 (en) * 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
US6503409B1 (en) * 2000-05-25 2003-01-07 Sandia Corporation Lithographic fabrication of nanoapertures
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
AU6501201A (en) 2000-06-01 2001-12-11 Science Applic Int Corp Systems and methods for monitoring health and delivering drugs transdermally
US8366769B2 (en) 2000-06-01 2013-02-05 Edwards Lifesciences Corporation Low-profile, pivotable heart valve sewing ring
US7473244B2 (en) * 2000-06-02 2009-01-06 The University Of Utah Research Foundation Active needle devices with integrated functionality
US6540675B2 (en) * 2000-06-27 2003-04-01 Rosedale Medical, Inc. Analyte monitor
US20040175360A1 (en) * 2000-06-29 2004-09-09 Pettis Ronald J. Method for altering drug pharmacokinetics based on medical delivery platform
US20050008683A1 (en) * 2000-06-29 2005-01-13 Becton Dickinson And Company Method for delivering interferons to the intradermal compartment
US6771183B2 (en) * 2000-07-03 2004-08-03 Kodiak Technologies, Inc. Advanced thermal container
US7399599B2 (en) 2000-07-10 2008-07-15 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
US7615356B2 (en) * 2000-07-10 2009-11-10 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
US6533951B1 (en) * 2000-07-27 2003-03-18 Eastman Kodak Company Method of manufacturing fluid pump
US6562404B1 (en) * 2000-08-25 2003-05-13 The Regents Of The University Of California Conformal chemically resistant coatings for microflow devices
US6533949B1 (en) * 2000-08-28 2003-03-18 Nanopass Ltd. Microneedle structure and production method therefor
US6690959B2 (en) 2000-09-01 2004-02-10 Medtronic, Inc. Skin-mounted electrodes with nano spikes
DE10048375A1 (en) * 2000-09-29 2002-05-08 Michele Delsanter Multifunctional and multiparametric biochip arrangement
US6787339B1 (en) * 2000-10-02 2004-09-07 Motorola, Inc. Microfluidic devices having embedded metal conductors and methods of fabricating said devices
US6821281B2 (en) 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
US7131987B2 (en) 2000-10-16 2006-11-07 Corium International, Inc. Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation
US7828827B2 (en) * 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
DE10053974A1 (en) 2000-10-31 2002-05-29 Roche Diagnostics Gmbh Blood collection system
KR20020035694A (en) * 2000-11-07 2002-05-15 양상식 A micro syringe device and the manufacturing method
US6537437B1 (en) 2000-11-13 2003-03-25 Sandia Corporation Surface-micromachined microfluidic devices
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
WO2002064193A2 (en) * 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
AU2002231207A1 (en) * 2000-12-21 2002-07-01 Biovalve Technologies, Inc. Microneedle array systems
AU2002247008B2 (en) * 2001-01-22 2006-02-09 F. Hoffmann-La Roche Ag Lancet device having capillary action
US6756018B2 (en) * 2001-02-12 2004-06-29 Agilent Technologies, Inc. Method and apparatus for selective execution of microfluidic circuits utilizing electrically addressable gas generators
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
US7310543B2 (en) 2001-03-26 2007-12-18 Kumetrix, Inc. Silicon microprobe with integrated biosensor
BR0116972A (en) * 2001-04-13 2004-12-21 Becton Dickinson Co Methods and devices for administering substances to the intradermal skin layer for systemic absorption
US6591124B2 (en) 2001-05-11 2003-07-08 The Procter & Gamble Company Portable interstitial fluid monitoring system
US20020177763A1 (en) * 2001-05-22 2002-11-28 Burns David W. Integrated lancets and methods
US20020188310A1 (en) * 2001-06-08 2002-12-12 Seward Kirk Partick Microfabricated surgical device
AU2002312380A1 (en) * 2001-06-08 2002-12-23 Becton, Dickinson And Company Device for manipulating a needle or abrader array
US20020188223A1 (en) 2001-06-08 2002-12-12 Edward Perez Devices and methods for the expression of bodily fluids from an incision
ATE335435T1 (en) 2001-06-08 2006-09-15 Hoffmann La Roche BODY FLUID EXTRACTION DEVICE AND TEST MEDIA CASSETTE
US7127284B2 (en) * 2001-06-11 2006-10-24 Mercator Medsystems, Inc. Electroporation microneedle and methods for its use
ATE497731T1 (en) * 2001-06-12 2011-02-15 Pelikan Technologies Inc DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK
US9226699B2 (en) * 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2003088851A1 (en) * 2001-06-12 2003-10-30 Pelikan Technologies, Inc. Tissue penetration device
CA2448905C (en) * 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Blood sampling apparatus and method
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
WO2002100253A2 (en) * 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Blood sampling device with diaphragm actuated lancet
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7316700B2 (en) * 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
ATE485766T1 (en) * 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7025774B2 (en) * 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US6767341B2 (en) 2001-06-13 2004-07-27 Abbott Laboratories Microneedles for minimally invasive drug delivery
MXPA03011611A (en) * 2001-06-29 2004-07-01 Becton Dickinson Co Intradermal delivery of vaccines and gene therapeutic agents via microcannula.
US20030073609A1 (en) * 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
US20050010193A1 (en) * 2002-05-06 2005-01-13 Laurent Philippe E. Novel methods for administration of drugs and devices useful thereof
DE10134650B4 (en) * 2001-07-20 2009-12-03 Roche Diagnostics Gmbh System for taking small amounts of body fluid
US6825127B2 (en) 2001-07-24 2004-11-30 Zarlink Semiconductor Inc. Micro-fluidic devices
DE10142232B4 (en) * 2001-08-29 2021-04-29 Roche Diabetes Care Gmbh Process for the production of an analytical aid with a lancet and test element
EP1423049A2 (en) * 2001-08-29 2004-06-02 Roche Diagnostics GmbH Wicking methods and structures for use in sampling bodily fluids
US20040087992A1 (en) * 2002-08-09 2004-05-06 Vladimir Gartstein Microstructures for delivering a composition cutaneously to skin using rotatable structures
WO2003024507A2 (en) * 2001-09-19 2003-03-27 Biovalve Technologies, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
WO2003024508A2 (en) * 2001-09-21 2003-03-27 Biovalve Technologies, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same
WO2003039369A1 (en) * 2001-09-26 2003-05-15 Roche Diagnostics Gmbh Method and apparatus for sampling bodily fluid
CA2500453A1 (en) * 2001-09-28 2003-04-03 Biovalve Technologies, Inc. Microneedle with membrane
CA2500452A1 (en) * 2001-09-28 2003-04-03 Biovalve Technologies, Inc. Switchable microneedle arrays and systems and methods relating to same
US6788966B2 (en) * 2001-10-22 2004-09-07 Transscan Medical Ltd. Diagnosis probe
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US20040120964A1 (en) * 2001-10-29 2004-06-24 Mikszta John A. Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
JP2005511248A (en) * 2001-10-29 2005-04-28 ベクトン・ディキンソン・アンド・カンパニー Methods and devices for delivering substances
US7209788B2 (en) * 2001-10-29 2007-04-24 Duke University Closed loop brain machine interface
US6989891B2 (en) * 2001-11-08 2006-01-24 Optiscan Biomedical Corporation Device and method for in vitro determination of analyte concentrations within body fluids
US20030105409A1 (en) * 2001-11-14 2003-06-05 Donoghue John Philip Neurological signal decoding
US20040005258A1 (en) * 2001-12-12 2004-01-08 Fonash Stephen J. Chemical reactor templates: sacrificial layer fabrication and template use
US20040073175A1 (en) * 2002-01-07 2004-04-15 Jacobson James D. Infusion system
US7309620B2 (en) * 2002-01-11 2007-12-18 The Penn State Research Foundation Use of sacrificial layers in the manufacture of high performance systems on tailored substrates
US20040060902A1 (en) * 2002-02-05 2004-04-01 Evans John D. Microprotrusion array and methods of making a microprotrusion
US7004928B2 (en) * 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
JP3933058B2 (en) * 2002-02-25 2007-06-20 日立化成工業株式会社 Support unit for microfluidic system and method for manufacturing the same
CA2419200C (en) * 2002-03-05 2015-06-30 Bayer Healthcare Llc Fluid collection apparatus having an integrated lance and reaction area
US6993392B2 (en) * 2002-03-14 2006-01-31 Duke University Miniaturized high-density multichannel electrode array for long-term neuronal recordings
US7371247B2 (en) * 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7141058B2 (en) * 2002-04-19 2006-11-28 Pelikan Technologies, Inc. Method and apparatus for a body fluid sampling device using illumination
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) * 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) * 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7297122B2 (en) * 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7582099B2 (en) * 2002-04-19 2009-09-01 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) * 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
AU2003231749A1 (en) * 2002-04-19 2003-11-03 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) * 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7291117B2 (en) * 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) * 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7524293B2 (en) * 2002-04-19 2009-04-28 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7481776B2 (en) * 2002-04-19 2009-01-27 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) * 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7563232B2 (en) * 2002-04-19 2009-07-21 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7374544B2 (en) * 2002-04-19 2008-05-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892185B2 (en) * 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7892183B2 (en) * 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) * 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) * 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7244265B2 (en) * 2002-04-19 2007-07-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) * 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7410468B2 (en) * 2002-04-19 2008-08-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
WO2004054455A1 (en) * 2002-12-13 2004-07-01 Pelikan Technologies, Inc. Method and apparatus for measuring analytes
US20070142748A1 (en) * 2002-04-19 2007-06-21 Ajay Deshmukh Tissue penetration device
US8267870B2 (en) * 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US9795334B2 (en) * 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7485128B2 (en) * 2002-04-19 2009-02-03 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US9314194B2 (en) * 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
JP4764626B2 (en) 2002-05-06 2011-09-07 ベクトン・ディキンソン・アンド・カンパニー Method and device for controlling the pharmacokinetics of a drug
US20060264886A9 (en) * 2002-05-06 2006-11-23 Pettis Ronald J Method for altering insulin pharmacokinetics
US20030143113A2 (en) * 2002-05-09 2003-07-31 Lifescan, Inc. Physiological sample collection devices and methods of using the same
US20030212344A1 (en) * 2002-05-09 2003-11-13 Vadim Yuzhakov Physiological sample collection devices and methods of using the same
US20030211619A1 (en) * 2002-05-09 2003-11-13 Lorin Olson Continuous strip of fluid sampling and testing devices and methods of making, packaging and using the same
US7060192B2 (en) * 2002-05-09 2006-06-13 Lifescan, Inc. Methods of fabricating physiological sample collection devices
KR100479687B1 (en) * 2002-05-30 2005-03-30 한국과학기술연구원 Cantilever sensor and method for fabrication thereof
US20030223906A1 (en) 2002-06-03 2003-12-04 Mcallister Devin Test strip container system
WO2003101532A2 (en) * 2002-06-04 2003-12-11 Cyberkinetics, Inc. Optically-connected implants and related systems and methods of use
US7115881B2 (en) * 2002-06-04 2006-10-03 Mario Rabinowitz Positioning and motion control by electrons, ions, and neutrals in electric fields
US20040067481A1 (en) * 2002-06-12 2004-04-08 Leslie Leonard Thermal sensor for fluid detection
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
JP2005537054A (en) * 2002-08-30 2005-12-08 ベクトン・ディキンソン・アンド・カンパニー Methods for controlling the pharmacokinetics of immunomodulatory compounds
AU2003275311A1 (en) * 2002-09-16 2004-04-30 Sung-Yun Kwon Solid micro-perforators and methods of use
IES20020794A2 (en) * 2002-10-04 2003-02-19 Minroc Techn Promotions Ltd A down-the-hole hammer
DE10247022B4 (en) * 2002-10-09 2016-09-08 Disetronic Licensing Ag pinpoint
US7212851B2 (en) 2002-10-24 2007-05-01 Brown University Research Foundation Microstructured arrays for cortex interaction and related methods of manufacture and use
US20050049522A1 (en) * 2002-10-30 2005-03-03 Allen John J Method of lancing skin for the extraction of blood
US7731900B2 (en) * 2002-11-26 2010-06-08 Roche Diagnostics Operations, Inc. Body fluid testing device
US20040178879A1 (en) * 2002-12-13 2004-09-16 Somenath Mitra Micromachined heaters for microfluidic devices
EP1578271B1 (en) 2002-12-23 2011-05-25 Roche Diagnostics GmbH Body fluid testing device
US7582258B2 (en) * 2002-12-23 2009-09-01 Roche Diagnostics Operations, Inc. Body fluid testing device
US7815579B2 (en) * 2005-03-02 2010-10-19 Roche Diagnostics Operations, Inc. Dynamic integrated lancing test strip with sterility cover
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
WO2004071737A2 (en) * 2003-02-04 2004-08-26 Arizona Board Of Regents, Acting For And On Behalf Of Arizona State University (Abr/Asu) Using benzocyclobutene as a biocompatible material
KR100562498B1 (en) * 2003-02-12 2006-03-21 삼성전자주식회사 Pad conditioner of cmp equipment
US7578954B2 (en) * 2003-02-24 2009-08-25 Corium International, Inc. Method for manufacturing microstructures having multiple microelements with through-holes
US7052652B2 (en) 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
US20080149524A1 (en) * 2003-03-27 2008-06-26 Rademaker William B Food containers including dental cleaning devices and other personal care items
US20040193202A1 (en) * 2003-03-28 2004-09-30 Allen John J. Integrated lance and strip for analyte measurement
US7473264B2 (en) * 2003-03-28 2009-01-06 Lifescan, Inc. Integrated lance and strip for analyte measurement
US20040193072A1 (en) * 2003-03-28 2004-09-30 Allen John J. Method of analyte measurement using integrated lance and strip
US20050070819A1 (en) * 2003-03-31 2005-03-31 Rosedale Medical, Inc. Body fluid sampling constructions and techniques
DE10315544B4 (en) * 2003-04-04 2007-02-15 Roche Diagnostics Gmbh Method for producing a piercing and measuring device and device
WO2004103147A2 (en) * 2003-05-02 2004-12-02 Pelikan Technologies, Inc. Method and apparatus for a tissue penetrating device user interface
JP2004343275A (en) * 2003-05-14 2004-12-02 Murata Mach Ltd Image processing system and scanner
US7374949B2 (en) * 2003-05-29 2008-05-20 Bayer Healthcare Llc Diagnostic test strip for collecting and detecting an analyte in a fluid sample
ATE476137T1 (en) 2003-05-30 2010-08-15 Pelikan Technologies Inc METHOD AND DEVICE FOR INJECTING LIQUID
WO2004107964A2 (en) * 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
US20040249302A1 (en) * 2003-06-09 2004-12-09 Cyberkinetics, Inc. Methods and systems for processing of brain signals
US20060241666A1 (en) * 2003-06-11 2006-10-26 Briggs Barry D Method and apparatus for body fluid sampling and analyte sensing
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US20050163711A1 (en) * 2003-06-13 2005-07-28 Becton, Dickinson And Company, Inc. Intra-dermal delivery of biologically active agents
WO2005020912A2 (en) * 2003-08-25 2005-03-10 3M Innovative Properties Company Delivery of immune response modifier compounds
MXPA06002159A (en) * 2003-08-26 2006-05-22 Becton Dickinson Co Methods for intradermal delivery of therapeutics agents.
US8353861B2 (en) * 2003-09-18 2013-01-15 Texmac, Inc. Applicator for applying functional substances into human skin
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
EP1680014A4 (en) * 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US20050143589A1 (en) * 2003-11-09 2005-06-30 Donoghue John P. Calibration systems and methods for neural interface devices
US20050113744A1 (en) * 2003-11-21 2005-05-26 Cyberkinetics, Inc. Agent delivery systems and related methods under control of biological electrical signals
US7751877B2 (en) * 2003-11-25 2010-07-06 Braingate Co., Llc Neural interface system with embedded id
EP1703925A1 (en) * 2003-11-27 2006-09-27 Commissariat A L'Energie Atomique In vivo diagnostic and therapy micro-device
US8017145B2 (en) * 2003-12-22 2011-09-13 Conopco, Inc. Exfoliating personal care wipe article containing an array of projections
US7647097B2 (en) * 2003-12-29 2010-01-12 Braingate Co., Llc Transcutaneous implant
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) * 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US7871435B2 (en) 2004-01-23 2011-01-18 Edwards Lifesciences Corporation Anatomically approximate prosthetic mitral heart valve
CN100571860C (en) * 2004-02-18 2009-12-23 日立化成工业株式会社 Micro fluid system support unit
US20050187525A1 (en) * 2004-02-19 2005-08-25 Hilgers Michael E. Devices and methods for extracting bodily fluid
US20050256499A1 (en) * 2004-03-03 2005-11-17 Pettis Ronald J Methods and devices for improving delivery of a substance to skin
PL1725168T3 (en) * 2004-03-06 2016-10-31 Body fluid sampling device
US20050203366A1 (en) * 2004-03-12 2005-09-15 Donoghue John P. Neurological event monitoring and therapy systems and related methods
US20050203575A1 (en) * 2004-03-15 2005-09-15 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin microactivation system and method
AU2005228145B2 (en) * 2004-03-24 2011-03-03 Corium Pharma Solutions, Inc. Transdermal delivery device
US8024036B2 (en) 2007-03-19 2011-09-20 The Invention Science Fund I, Llc Lumen-traveling biological interface device and method of use
US20070010868A1 (en) * 2004-04-19 2007-01-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Lumenally-active device
US8512219B2 (en) * 2004-04-19 2013-08-20 The Invention Science Fund I, Llc Bioelectromagnetic interface system
US8353896B2 (en) * 2004-04-19 2013-01-15 The Invention Science Fund I, Llc Controllable release nasal system
US7850676B2 (en) * 2004-04-19 2010-12-14 The Invention Science Fund I, Llc System with a reservoir for perfusion management
US20070244520A1 (en) * 2004-04-19 2007-10-18 Searete Llc Lumen-traveling biological interface device and method of use
US8361013B2 (en) * 2004-04-19 2013-01-29 The Invention Science Fund I, Llc Telescoping perfusion management system
US7998060B2 (en) * 2004-04-19 2011-08-16 The Invention Science Fund I, Llc Lumen-traveling delivery device
US7857767B2 (en) * 2004-04-19 2010-12-28 Invention Science Fund I, Llc Lumen-traveling device
US8337482B2 (en) * 2004-04-19 2012-12-25 The Invention Science Fund I, Llc System for perfusion management
US8092549B2 (en) * 2004-09-24 2012-01-10 The Invention Science Fund I, Llc Ciliated stent-like-system
US9011329B2 (en) * 2004-04-19 2015-04-21 Searete Llc Lumenally-active device
WO2005115360A2 (en) * 2004-05-11 2005-12-08 Becton, Dickinson And Company Formulations of anti-pain agents and methods of using the same
US7591806B2 (en) * 2004-05-18 2009-09-22 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US8828203B2 (en) * 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US20050284757A1 (en) * 2004-06-29 2005-12-29 Allen John J Analyte measuring system which prevents the reuse of a test strip
US20050284773A1 (en) * 2004-06-29 2005-12-29 Allen John J Method of preventing reuse in an analyte measuring system
US20060030788A1 (en) * 2004-08-04 2006-02-09 Daniel Wong Apparatus and method for extracting bodily fluid utilizing a flat lancet
US20060058627A1 (en) * 2004-08-13 2006-03-16 Flaherty J C Biological interface systems with wireless connection and related methods
US8560041B2 (en) * 2004-10-04 2013-10-15 Braingate Co., Llc Biological interface system
DE102004048864A1 (en) * 2004-10-07 2006-04-13 Roche Diagnostics Gmbh Analytical test element with wireless data transmission
US7627938B2 (en) * 2004-10-15 2009-12-08 Board Of Regents, The Univeristy Of Texas System Tapered hollow metallic microneedle array assembly and method of making and using the same
CA2587216C (en) * 2004-11-18 2014-11-18 Nanopass Technologies Ltd. System and method for delivering fluid into flexible biological barrier
JP4687653B2 (en) * 2004-11-30 2011-05-25 日立化成工業株式会社 Analysis pretreatment parts
JP2008522875A (en) 2004-12-07 2008-07-03 スリーエム イノベイティブ プロパティズ カンパニー Microneedle molding method
CN101664662A (en) * 2004-12-09 2010-03-10 日立化成工业株式会社 Support unit for micro fluid system and process for producing the same
EP1671585A1 (en) * 2004-12-17 2006-06-21 F. Hoffmann-La Roche Ag Method of manufacturing a lancet element
US20060167382A1 (en) * 2004-12-30 2006-07-27 Ajay Deshmukh Method and apparatus for storing an analyte sampling and measurement device
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US20080214917A1 (en) * 2004-12-30 2008-09-04 Dirk Boecker Method and apparatus for analyte measurement test time
US7901368B2 (en) * 2005-01-06 2011-03-08 Braingate Co., Llc Neurally controlled patient ambulation system
US7991461B2 (en) * 2005-01-06 2011-08-02 Braingate Co., Llc Patient training routine for biological interface system
US8095209B2 (en) * 2005-01-06 2012-01-10 Braingate Co., Llc Biological interface system with gated control signal
US20060167564A1 (en) * 2005-01-10 2006-07-27 Flaherty J C Limb and digit movement system
WO2006076175A2 (en) * 2005-01-10 2006-07-20 Cyberkinetics Neurotechnology Systems, Inc. Biological interface system with patient training apparatus
US7881780B2 (en) * 2005-01-18 2011-02-01 Braingate Co., Llc Biological interface system with thresholded configuration
US20060184065A1 (en) * 2005-02-10 2006-08-17 Ajay Deshmukh Method and apparatus for storing an analyte sampling and measurement device
US7955271B2 (en) * 2006-10-13 2011-06-07 Roche Diagnostics Operations, Inc. Tape transport lance sampler
US7935063B2 (en) * 2005-03-02 2011-05-03 Roche Diagnostics Operations, Inc. System and method for breaking a sterility seal to engage a lancet
KR100787598B1 (en) * 2005-05-17 2007-12-21 주식회사 크라또 Probe unit and method of fabricating the probe unit
US8048017B2 (en) * 2005-05-18 2011-11-01 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US8043250B2 (en) * 2005-05-18 2011-10-25 Nanomed Devices, Inc. High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US20060281187A1 (en) * 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
WO2007002522A1 (en) 2005-06-27 2007-01-04 3M Innovative Properties Company Microneedle cartridge assembly and method of applying
CN101687094B (en) * 2005-09-06 2012-09-26 谢拉杰克特股份有限公司 Solid solution perforator containing drug particle and/or drug-adsorbed particles
CA2623589C (en) * 2005-09-30 2014-07-22 Intuity Medical, Inc. Catalysts for body fluid sample extraction
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US20070191736A1 (en) * 2005-10-04 2007-08-16 Don Alden Method for loading penetrating members in a collection device
US20070276290A1 (en) * 2005-10-04 2007-11-29 Dirk Boecker Tissue Penetrating Apparatus
WO2007044599A2 (en) * 2005-10-06 2007-04-19 Hamilton Scott E Pod connected data monitoring system
US20070106143A1 (en) * 2005-11-08 2007-05-10 Flaherty J C Electrode arrays and related methods
US20080262416A1 (en) * 2005-11-18 2008-10-23 Duan Daniel C Microneedle Arrays and Methods of Preparing Same
US7651946B2 (en) * 2005-12-12 2010-01-26 University College Cork - National University Of Ireland, Cork Wet etch processing
US8308960B2 (en) 2005-12-14 2012-11-13 Silex Microsystems Ab Methods for making micro needles and applications thereof
ES2326286T3 (en) 2005-12-19 2009-10-06 F. Hoffmann-La Roche Ag SANDWICH TYPE SENSOR TO DETERMINE THE CONCENTRATION OF AN ANALYTE.
EP1797817A1 (en) 2005-12-19 2007-06-20 F.Hoffmann-La Roche Ag Sandwich sensor for determining the concentration of an analyte
US20070156126A1 (en) * 2005-12-29 2007-07-05 Flaherty J C Medical device insertion system and related methods
US20100023021A1 (en) * 2005-12-27 2010-01-28 Flaherty J Christopher Biological Interface and Insertion
US7699819B2 (en) 2006-02-21 2010-04-20 The Hong Kong University Of Science And Technology Molecular sieve and zeolite microneedles and preparation thereof
US9198563B2 (en) 2006-04-12 2015-12-01 The Invention Science Fund I, Llc Temporal control of a lumen traveling device in a body tube tree
EP3282250B1 (en) 2006-08-08 2020-04-08 Roche Diabetes Care GmbH Electrochemical sensor for determining an analyte concentration
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
CN101516396B (en) 2006-09-26 2013-10-09 传染性疾病研究院 Vaccine composition containing synthetic adjuvant
US8852124B2 (en) * 2006-10-13 2014-10-07 Roche Diagnostics Operations, Inc. Tape transport lance sampler
US20080214987A1 (en) * 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US10525246B2 (en) 2006-12-22 2020-01-07 Nanomed Skincare, Inc. Microdevice and method for transdermal delivery and sampling of active substances
AU2008209537B2 (en) * 2007-01-22 2013-01-31 Corium Pharma Solutions, Inc. Applicators for microneedle arrays
US7799656B2 (en) * 2007-03-15 2010-09-21 Dalsa Semiconductor Inc. Microchannels for BioMEMS devices
ES2817249T3 (en) 2007-04-16 2021-04-06 Corium Inc Microneedle matrices obtained by dissolution and casting containing an active principle
EP1987761B1 (en) * 2007-05-03 2019-10-23 F. Hoffmann-La Roche AG Tube-like sensor for proving an analyte
WO2009029572A1 (en) * 2007-08-24 2009-03-05 Deka Products Limited Partnership Microneedle systems and apparatus
WO2009051901A2 (en) 2007-08-30 2009-04-23 Pepex Biomedical, Llc Electrochemical sensor and method for manufacturing
US8702932B2 (en) 2007-08-30 2014-04-22 Pepex Biomedical, Inc. Electrochemical sensor and method for manufacturing
WO2009048607A1 (en) * 2007-10-10 2009-04-16 Corium International, Inc. Vaccine delivery via microneedle arrays
JP5178132B2 (en) * 2007-10-11 2013-04-10 キヤノン株式会社 Image processing system and image processing method
US20090209883A1 (en) * 2008-01-17 2009-08-20 Michael Higgins Tissue penetrating apparatus
US7766846B2 (en) 2008-01-28 2010-08-03 Roche Diagnostics Operations, Inc. Rapid blood expression and sampling
EP2100850A1 (en) * 2008-03-11 2009-09-16 Stichting Voor De Technische Wetenschappen Microneedle array and a method for manufacturing microneedles
EP2265324B1 (en) * 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
CN102105108B (en) * 2008-05-21 2013-12-04 谢拉杰克特股份有限公司 Method of manufacturing solid solution peforator patches and uses thereof
WO2009145920A1 (en) 2008-05-30 2009-12-03 Intuity Medical, Inc. Body fluid sampling device -- sampling site interface
US8886279B2 (en) * 2008-06-03 2014-11-11 University Of Utah Research Foundation High aspect ratio microelectrode arrays enabled to have customizable lengths and methods of making the same
JP5642066B2 (en) 2008-06-06 2014-12-17 インテュイティ メディカル インコーポレイテッド Method and apparatus for performing an assay to determine the presence or concentration of an analyte contained in a sample of body fluid
ES2907152T3 (en) 2008-06-06 2022-04-22 Intuity Medical Inc Blood glucose meter and method of operation
NL2001718C2 (en) * 2008-06-24 2009-12-28 Needle Holding B V U Micro needle, micro needle array and manufacturing method therefor.
US7927904B2 (en) 2009-01-05 2011-04-19 Dalsa Semiconductor Inc. Method of making BIOMEMS devices
US9375169B2 (en) * 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9980818B2 (en) 2009-03-31 2018-05-29 Edwards Lifesciences Corporation Prosthetic heart valve system with positioning markers
FI20095433A0 (en) * 2009-04-20 2009-04-20 Valtion Teknillinen micro-needle
BRPI1015460A2 (en) 2009-04-22 2020-08-18 Mercator Medsystems, Inc. guanetidine for use in the treatment of hypertension and hypertension treatment system
ES2634667T3 (en) * 2009-04-24 2017-09-28 Corium International, Inc. Methods for manufacturing microprojection assemblies
US8353953B2 (en) * 2009-05-13 2013-01-15 Sorin Biomedica Cardio, S.R.L. Device for the in situ delivery of heart valves
RU2560182C2 (en) 2009-06-05 2015-08-20 Инфекшес Дизиз Рисерч Инститьют Synthetic glucopyranosyllipid adjuvants
WO2011011462A1 (en) 2009-07-20 2011-01-27 Optiscan Biomedical Corporation Adjustable connector and dead space reduction
EP2506921A4 (en) 2009-11-30 2013-10-30 Univ South Florida Cubic silicon carbide implantable neural prosthetic
EP2506768B1 (en) 2009-11-30 2016-07-06 Intuity Medical, Inc. Calibration material delivery devices and methods
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
ES2719595T3 (en) 2010-05-04 2019-07-11 Corium Int Inc Method and device for transdermal administration of parathyroid hormone using a microprojection matrix
EP2584964B1 (en) 2010-06-25 2021-08-04 Intuity Medical, Inc. Analyte monitoring devices
WO2012075120A2 (en) 2010-11-30 2012-06-07 University Of South Florida Graphene electrodes on a planar cubic silicon carbide (3c-sic) long term implantable neuronal prosthetic device
WO2012098160A1 (en) 2011-01-18 2012-07-26 Imec Disposable protection for micro-engineered devices
EA027236B1 (en) 2011-04-08 2017-07-31 Иммьюн Дизайн Корп. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
US8945209B2 (en) 2011-05-20 2015-02-03 Edwards Lifesciences Corporation Encapsulated heart valve
EP4339613A2 (en) 2011-08-03 2024-03-20 Intuity Medical, Inc. Body fluid sampling arrangement
EP2570152B1 (en) 2011-09-16 2018-08-22 IMEC vzw Structured probes for neural applications
ES2549785T3 (en) * 2011-09-23 2015-11-02 F. Hoffmann-La Roche Ag Engraving procedure by mask of a puncture element
CA2887597C (en) 2011-10-19 2018-01-09 Mercator Medsystems, Inc. Localized modulation of tissues and cells to enhance therapeutic effects including renal denervation
US9872982B2 (en) 2012-01-10 2018-01-23 University of Pittsburgh—of the Commonwealth System of Higher Education Electroosmotic convection-enhanced delivery system
SI2811981T1 (en) 2012-02-07 2019-08-30 Infectious Disease Research Institute Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
ES2673556T3 (en) 2012-05-16 2018-06-22 Immune Design Corp. Vaccines for HSV-2
EP2925229A4 (en) 2012-12-03 2017-01-25 Pepex Biomedical, Inc. Sensor module and method of using a sensor module
CA2896188C (en) 2012-12-21 2021-02-23 Corium International, Inc. Microarray for delivery of therapeutic agent and methods of use
AU2014249471B2 (en) 2013-03-12 2019-01-24 Corium Pharma Solutions, Inc. Microprojection applicators
US11007058B2 (en) 2013-03-15 2021-05-18 Edwards Lifesciences Corporation Valved aortic conduits
US10004434B1 (en) 2013-03-15 2018-06-26 Georgetown University Microfluidic systems for electrochemical transdermal analyte sensing using a capillary-located electrode
SG11201506352SA (en) 2013-03-15 2015-09-29 Edwards Lifesciences Corp Valved aortic conduits
ES2939317T3 (en) 2013-03-15 2023-04-20 Corium Pharma Solutions Inc Multi-impact micro-spray applicators
MX2015012933A (en) 2013-03-15 2016-09-19 Corium Int Inc Microarray for delivery of therapeutic agent and methods of use.
JP2016512754A (en) 2013-03-15 2016-05-09 コリウム インターナショナル, インコーポレイテッド Microarray, method of use and manufacturing for delivery of therapeutic agents
CA2903763C (en) 2013-03-15 2021-11-16 Corium International, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
AU2014253791B2 (en) 2013-04-18 2019-05-02 Immune Design Corp. GLA monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
JP2016522070A (en) 2013-06-21 2016-07-28 インテュイティ メディカル インコーポレイテッド Analyte monitoring system using audible feedback
US11185271B2 (en) * 2013-09-13 2021-11-30 University Of Utah Research Foundation Methods of making micro-molded electrodes and arrays
SG11201508895RA (en) 2013-09-20 2015-11-27 Edwards Lifesciences Corp Heart valves with increased effective orifice area
GB201318700D0 (en) 2013-10-23 2013-12-04 Univ Swansea Manufacture of microneedles
US20150122687A1 (en) 2013-11-06 2015-05-07 Edwards Lifesciences Corporation Bioprosthetic heart valves having adaptive seals to minimize paravalvular leakage
SG11201605883UA (en) 2014-01-21 2016-08-30 Immune Design Corp Compositions for use in the treatment of allergic conditions
US9549816B2 (en) 2014-04-03 2017-01-24 Edwards Lifesciences Corporation Method for manufacturing high durability heart valve
CN107003264B (en) 2014-06-04 2020-02-21 普佩克斯生物医药有限公司 Electrochemical sensor and method of manufacturing an electrochemical sensor using advanced printing techniques
CA2914094C (en) 2014-06-20 2021-01-05 Edwards Lifesciences Corporation Surgical heart valves identifiable post-implant
USD867594S1 (en) 2015-06-19 2019-11-19 Edwards Lifesciences Corporation Prosthetic heart valve
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
WO2017004067A1 (en) 2015-06-29 2017-01-05 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
WO2017023931A1 (en) 2015-08-03 2017-02-09 Georgetown University Apparatus and method for delivery of antimicrobial during a transdermal sampling and delivery process
US10080653B2 (en) 2015-09-10 2018-09-25 Edwards Lifesciences Corporation Limited expansion heart valve
US10667904B2 (en) 2016-03-08 2020-06-02 Edwards Lifesciences Corporation Valve implant with integrated sensor and transmitter
MX2018013640A (en) 2016-05-16 2019-08-01 Infectious Disease Res Inst Pegylated liposomes and methods of use.
DK3458475T3 (en) 2016-05-16 2022-09-12 Access To Advanced Health Inst FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE
MX2021010105A (en) 2016-06-01 2022-06-16 Infectious Disease Res Inst Nanoalum particles containing a sizing agent.
CN110494126A (en) 2016-12-22 2019-11-22 俄亥俄州国家创新基金会 Run through micro-structure for the cargo delivering based on nanochannel
US10463485B2 (en) 2017-04-06 2019-11-05 Edwards Lifesciences Corporation Prosthetic valve holders with automatic deploying mechanisms
CA3060663A1 (en) 2017-04-28 2018-11-01 Edwards Lifesciences Corporation Prosthetic heart valve with collapsible holder
CA3066915A1 (en) 2017-06-11 2018-12-20 Molecular Express, Inc. Methods and compositions for substance use disorder vaccine formulations and uses thereof
CN110831547B (en) 2017-06-21 2022-07-15 爱德华兹生命科学公司 Double-wire limited expansion heart valve
EP4076284A1 (en) 2019-12-16 2022-10-26 Edwards Lifesciences Corporation Valve holder assembly with suture looping protection
EP4048308A1 (en) 2020-12-23 2022-08-31 Infectious Disease Research Institute Solanesol vaccine adjuvants and methods of preparing same
US11476897B2 (en) 2021-01-28 2022-10-18 Nucurrent, Inc. Wireless power transmitter for high fidelity communications at high power transfer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874499A (en) * 1988-05-23 1989-10-17 Massachusetts Institute Of Technology Electrochemical microsensors and method of making such sensors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221567A (en) * 1977-12-23 1980-09-09 Intermountain Health Care Sampling and determination of diffusible chemical substances
US4461304A (en) * 1979-11-05 1984-07-24 Massachusetts Institute Of Technology Microelectrode and assembly for parallel recording of neurol groups
NL8001420A (en) * 1980-03-10 1981-10-01 Cordis Europ ELECTRODE COMPOSITIVE COMPOSITE, FOR AN ELECTROCHEMICAL MEASUREMENT, IN PARTICULAR AN ISFET-CONSTRUCTED COMPOSITION, AND METHOD FOR MANUFACTURING THE ASSEMBLY.
GB2096825A (en) * 1981-04-09 1982-10-20 Sibbald Alastair Chemical sensitive semiconductor field effect transducer
US4969468A (en) * 1986-06-17 1990-11-13 Alfred E. Mann Foundation For Scientific Research Electrode array for use in connection with a living body and method of manufacture
US4902278A (en) * 1987-02-18 1990-02-20 Ivac Corporation Fluid delivery micropump
FR2648353B1 (en) * 1989-06-16 1992-03-27 Europhor Sa MICRODIALYSIS PROBE
US5285131A (en) * 1990-12-03 1994-02-08 University Of California - Berkeley Vacuum-sealed silicon incandescent light
US5130276A (en) * 1991-05-16 1992-07-14 Motorola Inc. Method of fabricating surface micromachined structures
US5498392A (en) * 1992-05-01 1996-03-12 Trustees Of The University Of Pennsylvania Mesoscale polynucleotide amplification device and method
US5304487A (en) * 1992-05-01 1994-04-19 Trustees Of The University Of Pennsylvania Fluid handling in mesoscale analytical devices
US5486335A (en) * 1992-05-01 1996-01-23 Trustees Of The University Of Pennsylvania Analysis based on flow restriction
US5296375A (en) * 1992-05-01 1994-03-22 Trustees Of The University Of Pennsylvania Mesoscale sperm handling devices

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874499A (en) * 1988-05-23 1989-10-17 Massachusetts Institute Of Technology Electrochemical microsensors and method of making such sensors

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1008315C2 (en) * 1998-02-16 1999-08-25 Stichting Fund Ond Material Microdialysis probe integrated with Si chip.
WO1999041606A1 (en) * 1998-02-16 1999-08-19 Stichting Voor Fundamenteel Onderzoek Der Materie Microdialysis-probe integrated with a si-chip
US8298487B2 (en) 2000-12-12 2012-10-30 Bayer Healthcare Llc Method of forming an electrochemical sensor
WO2002049507A1 (en) 2000-12-19 2002-06-27 Inverness Medical Limited Analyte measurement
EP1359837B1 (en) * 2000-12-19 2013-05-22 Lifescan Scotland Ltd Analyte measurement
EP1267159A2 (en) * 2001-06-11 2002-12-18 Bayer Corporation Electrochemical sensor and method of making
US7122102B2 (en) 2001-06-11 2006-10-17 Bayer Healthcare Llc Electrochemical sensor
EP1267159A3 (en) * 2001-06-11 2004-06-16 Bayer Corporation Electrochemical sensor and method of making
EP1911394A1 (en) * 2006-10-14 2008-04-16 Roche Diagnostics GmbH Lancet with capillar channel
WO2008043498A1 (en) * 2006-10-14 2008-04-17 Roche Diagnostics Gmbh Lancet with capillary channel
EP1967581A1 (en) * 2007-03-08 2008-09-10 Interuniversitair Microelektronica Centrum CMOS compatible microneedle structures
US8452369B2 (en) * 2007-03-08 2013-05-28 Imec CMOS compatible microneedle structures
US9551698B2 (en) 2009-12-30 2017-01-24 Imec Microneedle
EP2708889A1 (en) * 2012-09-12 2014-03-19 Universität Leipzig Method and device for obtaining a tissue sample and for characterizing the tissue sample by determining at least one electrical property

Also Published As

Publication number Publication date
US5591139A (en) 1997-01-07
AU2907295A (en) 1996-01-04
US5855801A (en) 1999-01-05

Similar Documents

Publication Publication Date Title
US5855801A (en) IC-processed microneedles
Lin et al. Silicon-processed microneedles
Gardeniers et al. Silicon micromachined hollow microneedles for transdermal liquid transport
EP1695734B1 (en) Microneedles for minimally invasive drug delivery or for diagnostic sampling
US6558361B1 (en) Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
Aggarwal et al. Geometrical effects in mechanical characterizing of microneedle for biomedical applications
US7753888B2 (en) Method and/or apparatus for puncturing a surface for extraction, in situ analysis, and/or substance delivery using microneedles
US7285113B2 (en) Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
Stoeber et al. Arrays of hollow out-of-plane microneedles for drug delivery
US7344499B1 (en) Microneedle device for extraction and sensing of bodily fluids
Polla et al. Ferroelectric thin films in micro-electromechanical systems applications
Seidl et al. In-plane silicon probes for simultaneous neural recording and drug delivery
US6187210B1 (en) Epidermal abrasion device with isotropically etched tips, and method of fabricating such a device
EP1967581B1 (en) CMOS compatible method for manufacturing microneedle structures
US20070007240A1 (en) Wafer-level, polymer-based encapsulation for microstructure devices
EP0789146A1 (en) Microvalve and method of manufacturing the same, micropump using the microvalve and method of manufacturing the same, and apparatus using the micropump
KR100384283B1 (en) Single crystal silicon micro needle and method for manufacturing the same
EP1276426A2 (en) Systems and methods for the transport of fluids through a biological barrier and production techniques for such systems
WO2007122552A2 (en) Device for the controlled release of a substance and method of releasing a substance
Takei et al. Integration of out-of-plane silicon dioxide microtubes, silicon microprobes and on-chip NMOSFETs by selective vapor–liquid–solid growth
Sparks et al. Micromachined needles and lancets with design adjustable bevel angles
Mukerjee et al. Microneedle array with integrated microchannels for transdermal sample extraction and in situ analysis
Berry et al. Dermal ISF collection using a Si microneedle array
JP2002369816A (en) Hollow needle, inspection chip using the same and blood analyzer
Zhang et al. Micromachined needles for microbiological sample and drug delivery system

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK ES FI GB GE HU JP KE KG KP KR KZ LK LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA